Processing 00000000.tx.1: Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes Silvia Del Guerra, Roberto Lupi, Lorella Marselli, Matilde Masini, Marco Bugliani, Simone Sbrana, Scilla Torri, Maria Pollera, Ugo Boggi, Franco Mosca, Stefano Del Prato, and Piero Marchetti From the Department of Endocrinology and Metabolism, Metabolic Unit, Cisanello Hospital, Pisa, Italy  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  To shed further light on the primary alterations of insulin secretion in type 2 diabetes and the possible mechanisms involved, we studied several functional and molecular properties of islets isolated from the pancreata of 13 type 2 diabetic and 13 matched nondiabetic cadaveric organ donors. 

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "Molecular Defects of Pancreatic Islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in Human Type 2 Diabetes Silvia Del Guerra,"

Phrase: "Roberto Lupi,"

Phrase: "Lorella Marselli,"

Phrase: "Matilde Masini,"

Phrase: "Marco Bugliani,"

Phrase: "Simone Sbrana,"

Phrase: "Scilla Torri,"

Phrase: "Maria Pollera,"

Phrase: "Ugo Boggi,"

Phrase: "Franco Mosca,"

Phrase: "Stefano Del Prato,"

Phrase: "and"

Phrase: "Piero Marchetti From the Department of Endocrinology"

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Metabolic Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Cisanello Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Pisa,"

Phrase: "Italy  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "shed"

Phrase: "further light on the primary alterations of insulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C1306462:Light [Functional Concept]
   742   C1881376:Light [Qualitative Concept]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the possible mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "several functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "molecular properties of islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]

Phrase: "isolated from the pancreata of 13 type 2 diabetic"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   764   C0441730:Type 2 [Classification]
   742   C0205409:Isolated [Functional Concept]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1548221:Isolated [Idea or Concept]
   708   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   708 E C0370215:Isolate [Substance]
   708   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "13 matched nondiabetic cadaveric organ donors."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0029206:Organ Donors [Population Group]
   810 E C1548659:Organ donor [Idea or Concept]
   810 E C1716004:Organ donor [Clinical Attribute]
   799   C0013018:Donors [Population Group]
   799   C1527169:Donors [Finding]
   766 E C0040288:Donor [Population Group]
Processing 00000000.tx.2: Glucose-stimulated insulin secretion from type 2 diabetic islets was significantly lower than from control islets, whereas arginine- and glibenclamide-stimulated insulin release was less markedly affected. 

Phrase: "Glucose-stimulated insulin secretion from type 2 diabetic islets"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1256369:insulin secretion [Cell Function]
   762   C0421248:diabetic insulin [Finding]
   762   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "from control islets,"

Phrase: "whereas"

Phrase: "arginine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide-stimulated insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "less markedly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439092:less [Intellectual Product]
   861   C0522501:Markedly [Qualitative Concept]
   861   C0547044:Less [Qualitative Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.3: The defects were accompanied by reduced mRNA expression of GLUT1 and -2 and glucokinase and by diminished glucose oxidation. 

Phrase: "The defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243067:defects [Functional Concept]
   966 E C1457869:Defect [Functional Concept]
   966 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "were"

Phrase: "accompanied by reduced mRNA expression of GLUT1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1515670:mRNA Expression [Genetic Function]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1335837:GLUT1 [Gene or Genome]
   748   C1504631:Glut-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1705603:GLUT1 [Gene or Genome]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "and by diminished glucose oxidation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0030011:Oxidation [Molecular Function]
   760   C0205216:Diminished [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.4: In addition, AMP-activated protein kinase activation was reduced. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "AMP-activated protein kinase activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1819041:protein kinase activation [Cell Function]
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   771   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   708   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.5: Furthermore, the expression of insulin was decreased, and that of pancreatic duodenal homeobox-1 (PDX-1) and forkhead box O1 (Foxo-1) was increased. 

Phrase: "Furthermore,"

Phrase: "the expression of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "that of pancreatic duodenal homeobox-1 (PDX-1)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0242303:Homeo Box [Gene or Genome]
   753   C0598306:Homeo Box [Spatial Concept]

Phrase: "and"

Phrase: "forkhead box O1 (Foxo-1)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "was"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.6: Nitrotyrosine and 8-hydroxy-2'-deoxyguanosine concentrations, markers of oxidative stress, were significantly higher in type 2 diabetic than control islets, and they were correlated with the degree of glucose-stimulated insulin release impairment. 

Phrase: "Nitrotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "8-hydroxy-2'-deoxyguanosine concentrations,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0086045:Concentrations [Mental Process]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "markers of oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "significantly higher in type 2 diabetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than control islets,"

Phrase: "and"

Phrase: "they"

Phrase: "were"

Phrase: "correlated with the degree of glucose-stimulated insulin release impairment."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   757   C1719133:Glucose/Insulin [Quantitative Concept]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0441889:Degree [Qualitative Concept]
   739   C0449286:Degree [Quantitative Concept]
   739   C0542560:Degree [Intellectual Product]
   739   C0680255:release [Health Care Activity]
   739   C0684336:Impairment [Pathologic Function]
   739   C1283071:Release [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561545:degree [Quantitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1707520:Correlated [Qualitative Concept]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   739   C1963578:Release [Therapeutic or Preventive Procedure]
   739   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.7: Accordingly, 24-h exposure to glutathione significantly improved glucose-stimulated insulin release and decreased nitrotyrosine concentration, with partial recovery of insulin mRNA expression. 

Phrase: "Accordingly,"

Phrase: "24-h exposure to glutathione significantly improved glucose-stimulated insulin release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0332157:Exposure to [Clinical Attribute]
           Exposure
   738   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "and"

Phrase: "decreased nitrotyrosine concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "with partial recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237820:Recovery [Activity]
   861   C1555688:recovery [Idea or Concept]
   861   C2004454:Recovery [Organism Function]

Phrase: "of insulin mRNA expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.8: These results provide direct evidence that the defects of insulin secretion in type 2 diabetic islets are associated with multiple islet cell alterations. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the defects of insulin secretion"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in type 2 diabetic islets"

Phrase: "are"

Phrase: "associated with multiple islet cell alterations."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1522529:Islet Cell [Cell]
   783   C0699040:cell associated [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0439064:Multiple [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1515926:Alteration [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.9: Most importantly, the current study shows that the functional impairment of type 2 diabetic islets can be, at least in part, reversible. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the functional impairment of type 2 diabetic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]

Phrase: "can"

Phrase: "be"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "reversible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]
Processing 00000000.tx.10: In this regard, it is suggested that reducing islet cell oxidative stress is a potential target of human type 2 diabetes therapy. 

Phrase: "In this regard,"

Phrase: "it"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that reducing islet cell oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   804   C0038435:Stress [Finding]
   804   C0311404:Oxidative [Functional Concept]
   733 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "a potential target of human type 2 diabetes therapy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.11: Diabetes is a chronic metabolic syndrome caused by insulin deficiency. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "a chronic metabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0524620:Metabolic syndrome [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]
   827   C0311400:Metabolic [Functional Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]

Phrase: "caused by insulin deficiency."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.12: There are 200 million diabetic individuals in the world, with only about half being diagnosed, and these numbers are expected to double by 2030 (1). 

Phrase: "There"

Phrase: "are"

Phrase: "200 million diabetic individuals in the world,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "about half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "being"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: ","

Phrase: "and"

Phrase: "these numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "double by 2030"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Double [Functional Concept]
   790   C1705764:Double [Activity]
   790   C1705765:Double [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The disease often results in long-term microvascular, neurological, and macrovascular complications including retinopathy, nephropathy, neuropathy, and increased risk of cardiovascular disease (2). 

Phrase: "The disease often"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "results in long-term microvascular, neurological,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0443252:Long-term [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0205494:Neurological [Qualitative Concept]
   753   C0443258:Microvascular [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2707261:Neurological [Clinical Attribute]
   753   C2825142:Result [Finding]
   753   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "macrovascular complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "retinopathy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035309:Retinopathy [Disease or Syndrome]
  1000   C1962966:Retinopathy [Finding]

Phrase: "nephropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: "neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "increased risk of cardiovascular disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   751   C0277564:Acquired disease [Disease or Syndrome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Diabetes is the leading cause of blindness, lower limb amputations, and renal failure in the U.S. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is"

Phrase: "the leading cause of blindness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "lower limb amputations,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C0337308:Lower limb amputation [Therapeutic or Preventive Procedure]
   884   C0002689:Limb amputation [Therapeutic or Preventive Procedure]
   827   C0002688:Amputations [Therapeutic or Preventive Procedure]
   793 E C1546539:Amputation [Intellectual Product]
   734   C0023216:Lower Limb [Body Location or Region]
   734   C1269079:Lower limb [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "renal failure in the U.S."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0035078:Renal Failure [Disease or Syndrome]
   790   C1963154:Renal failure [Finding]
   753   C0022646:Renal [Body Part, Organ, or Organ Component]
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]
Processing 00000000.tx.15: The health care cost of diabetes is high, with the total estimated cost in the U.S. exceeding $100 billion (3). 

Phrase: "The health care cost of diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0085552:Health Care Cost [Quantitative Concept]
           Health Cost
   790   C0086388:Health Care [Health Care Activity]
   753   C0010186:Cost [Quantitative Concept]
   753   C0018684:Health [Idea or Concept]
   753   C0220812:cost [Quantitative Concept]
   753   C1947933:Care [Activity]

Phrase: "is"

Phrase: "high,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "with the total estimated cost"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010186:Cost [Quantitative Concept]
   827   C0220812:cost [Quantitative Concept]

Phrase: "in the U.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]

Phrase: "exceeding"

Phrase: "$100 billion"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Type 1 and type 2 diabetes are the two main forms of diabetes (4,5). 

Phrase: "Type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "the two main forms of diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: Type 1 diabetes is characterized by an absolute insulin insufficiency caused by the immunological destruction of pancreatic -cells, which produce and secrete insulin, and it accounts for 10% of all cases of diabetes. 

Phrase: "Type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by an absolute insulin insufficiency"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205344:Absolute [Qualitative Concept]
   753   C0231179:Insufficiency [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1880022:Characterized [Activity]

Phrase: "caused by the immunological destruction of pancreatic -cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0007634:Cells [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0205470:Immunological [Functional Concept]
   744   C1261381:Destruction [Therapeutic or Preventive Procedure]
   744   C1948029:Destruction [Activity]
   744   C3282337:Cells [Cell]
   711   C0015127:cause [Functional Concept]
   711 E C1269647:Cell [Cell]
   711   C1524003:Cause [Conceptual Entity]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "produce"

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "it"

Phrase: "accounts for 10% of all cases of diabetes."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   744   C1551359:account [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.18: Type 2 diabetes is more complex in etiology and is characterized by a relative insulin deficiency, reduced insulin action, and insulin resistance of glucose transport in skeletal muscle and adipose tissue. 

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "more complex in etiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "is"

Phrase: "characterized by a relative insulin deficiency,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0011155:Deficiency [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0080103:Relative [Family Group]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C0205345:Relative [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1547039:*Relative [Quantitative Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1623416:deficiency [Qualitative Concept]
   753   C1880022:Characterized [Activity]

Phrase: "reduced insulin action,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin resistance of glucose transport"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   797   C1719133:Glucose/Insulin [Quantitative Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.19: The manifestation of frank type 2 diabetes is a continuum of insulin resistance culminating in the failure of augmented insulin secretion to compensate for insulin resistance (6,7), and the progression to full diabetes ensues when pancreatic -cell hypersecretion of insulin fails to compensate for insulin resistance (7). 

Phrase: "The manifestation of frank type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   748   C0205319:manifestation [Functional Concept]

Phrase: "is"

Phrase: "a continuum of insulin resistance culminating"

Phrase: "in the failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "of augmented insulin secretion to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "compensate for insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205432:compensate [Qualitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the progression to full diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: "ensues"

Phrase: "when"

Phrase: "pancreatic -cell hypersecretion of insulin"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compensate for insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205432:compensate [Qualitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: Commonly found alterations of insulin secretion in type 2 diabetic patients include reduced or absent first-phase response to intravenous glucose (8), delayed or blunted release after ingestion of mixed meals (9), alterations in rapid pulses, and ultradian oscillations (10). 

Phrase: "Commonly found alterations of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "or"

Phrase: "absent first-phase response to intravenous glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "or"

Phrase: "blunted release after ingestion of mixed meals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "alterations in rapid pulses,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "ultradian oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.21: In addition, second-phase insulin secretion and response to nonglucose stimuli may also be reduced (11). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "second-phase insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "response to nonglucose stimuli"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C0424540:Response to stimulus [Mental Process]
   912   C0542478:response to stimulus [Physiologic Function]
   812   C0234402:Stimuli [Phenomenon or Process]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.22: Only limited information is available as for the properties of islets isolated from patients with type 2 diabetes. 

Phrase: "Only limited information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "available as for the properties of islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0470187:Available [Functional Concept]
           Availability of

Phrase: "isolated from patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.23: In cells prepared from two type 2 diabetic organ donors, a marked decrease of insulin secretion during glucose stimulation was found, although the secretory response to a combination of leucine and glutamine was less severely affected (12). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "prepared from two type 2 diabetic organ donors,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   770   C0029206:Organ Donors [Population Group]
   770   C0441730:Type 2 [Classification]
   754 E C1548659:Organ donor [Idea or Concept]
   754 E C1716004:Organ donor [Clinical Attribute]
   750 E C0348079:Donor organ [Body Part, Organ, or Organ Component]
   744   C0013018:Donors [Population Group]
   744   C0178784:Organ [Body Part, Organ, or Organ Component]
   744   C0205448:Two [Quantitative Concept]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1527169:Donors [Finding]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0040288:Donor [Population Group]
   711   C1521827:Prepare [Functional Concept]

Phrase: "a marked decrease of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "during glucose stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "although"

Phrase: "the secretory response to a combination of leucine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1523845:response to leucine [Organism Function]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "less severely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205082:Severely [Qualitative Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.24: In addition, the activity of FAD-glycerophosphate dehydrogenase, glutamate-oxalacetate transaminase, or glutamate-pyruvate transaminase was lower in type 2 diabetic islets than in control cells (12). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the activity of FAD-glycerophosphate dehydrogenase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1151278:glycerophosphate dehydrogenase activity [Amino Acid, Peptide, or Protein,Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "glutamate-oxalacetate transaminase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002594:Transaminase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "glutamate-pyruvate transaminase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0001899:Glutamate pyruvate transaminase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415274:GLUTAMATE PYRUVATE TRANSAMINASE [Gene or Genome]
   827   C0002594:Transaminase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "was"

Phrase: "lower in type 2 diabetic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.25: Lin et al. 

Phrase: "Lin et al."
Processing 00000000.tx.26: (13) observed that the islets from three type 2 diabetic donors released insulin in pulses with reduced amplitude. 

Phrase: "(13"

Phrase: ")"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the islets from three type 2 diabetic donors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   750   C1425576:ISLET 2 [Gene or Genome]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "insulin in pulses"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with reduced amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.27: More recently, type 2 diabetic islets were shown to have abnormal glucose-induced insulin release during perifusion experiments and reduced efficacy in curing immunodeficient diabetic mice by transplantation (14). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "type 2 diabetic islets"

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "abnormal glucose-induced insulin release during perifusion experiments"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reduced efficacy in curing immunodeficient diabetic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:Efficacy [Qualitative Concept]
   748   C1707887:EFFICACY [Research Activity]

Phrase: "by transplantation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.28: In the current study, we prepared isolated islets from the pancreata of 13 type 2 diabetic patients and studied several of their properties, including insulin release in response to glucose and nonglucose stimuli, gene/protein expression of molecules involved in -cell function, and the concentration of markers of oxidative stress. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "isolated islets from the pancreata of 13 type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1425576:ISLET 2 [Gene or Genome]

Phrase: "and"

Phrase: "studied several of their properties,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin release in response"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "nonglucose stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "gene/protein expression of molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1171362:protein expression [Genetic Function]
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell function,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "the concentration of markers of oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.29: We found multiple alterations of type 2 diabetic islets, which could be reversed, in part, by reducing oxidative stress.  

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "multiple alterations of type 2 diabetic islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by reducing oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.30: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  From July 2001 to June 2004, a total of 147 human pancreata were processed for islet isolation in our laboratory. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  From July 2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]

Phrase: "to June 2004,"

Phrase: "a total of 147 human pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "processed for islet isolation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "in our laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.31: In this series, there were 13 pancreata from cadaveric donors who were diagnosed as type 2 diabetic patients on the basis of currently accepted criteria (4). 

Phrase: "In this series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "there"

Phrase: "were"

Phrase: "13 pancreata from cadaveric donors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   726   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "who"

Phrase: "were"

Phrase: "diagnosed as type 2 diabetic patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0441730:Type 2 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0011900:Diagnosed [Finding]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "on the basis of currently accepted criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.32: The results obtained with the islets from these isolations were compared with those of 13 isolations from nondiabetic donors (Table 1) matched for age, BMI, cause of death, cold ischemia time, collagenase lot, and duration of isolation process. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with the islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from these isolations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0204727:isolations [Therapeutic or Preventive Procedure]
   966 E C0205409:Isolation [Functional Concept]
   966 E C0220862:isolation [Laboratory Procedure]
   916 E C1548221:Isolated [Idea or Concept]

Phrase: "were"

Phrase: "compared with those of 13 isolations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0204727:isolations [Therapeutic or Preventive Procedure]
   753   C1707455:Compared [Activity]
   719 E C0205409:Isolation [Functional Concept]
   719 E C0220862:isolation [Laboratory Procedure]

Phrase: "from nondiabetic donors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013018:Donors [Population Group]
   861   C1527169:Donors [Finding]
   827 E C0040288:Donor [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "matched for age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0150103:matched [Research Activity]
   790   C1708943:Matched [Qualitative Concept]

Phrase: "BMI,"

Phrase: "cause of death,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007465:Cause of Death [Finding]
           Death Cause
  1000   C0804771:Cause of death [Clinical Attribute]
   790   C0015127:cause [Functional Concept]
   790   C1524003:Cause [Conceptual Entity]

Phrase: "cold ischemia time,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C1563922:Cold Ischemia Time [Temporal Concept]
   901   C1563921:Cold Ischemia [Disease or Syndrome]
   901   C2986707:cold ischemia [Therapeutic or Preventive Procedure]
   827   C0009264:Cold [Natural Phenomenon or Process]
   827   C0009443:Cold [Disease or Syndrome]
   827   C0022116:Ischaemia [Disease or Syndrome]
   827   C0040223:Time [Temporal Concept]
   827   C0234192:Cold [Physiologic Function]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0475224:Ischaemic [Functional Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "collagenase lot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1115660:LOT [Intellectual Product]
   861   C1518000:Lot [Qualitative Concept]
   861   C1710198:Lot [Idea or Concept]

Phrase: "and"

Phrase: "duration of isolation process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.33: All pancreata studied were obtained and processed with the approval of the ethics committee of our institution. 

Phrase: "All pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "processed with the approval of the ethics committee of our institution."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   756   C0085546:Ethics Committee [Professional or Occupational Group]
   748   C0086471:Institutional Ethics Committee [Professional or Occupational Group]
   738   C0015000:Ethics [Idea or Concept]
   738   C0018704:Institution [Health Care Related Organization,Manufactured Object]
   738   C0205540:Approval [Qualitative Concept]
   738   C1272753:Institution [Idea or Concept]
   738   C1522240:Processed [Phenomenon or Process]
   738   C1527243:ethics [Idea or Concept]
   738   C2346845:Approval [Intellectual Product]
   738   C2607850:Institution [Health Care Related Organization]
   738   C2699414:Committee [Group]
   718   C0015003:Ethics, Institutional [Idea or Concept]
   704 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.34: The islets were isolated by enzymatic digestion and density gradient purification, as previously described (1518). 

Phrase: "The islets"

Phrase: "were"

Phrase: "isolated by enzymatic digestion"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0012238:Digestion [Organism Function]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2349986:Digestion [Research Activity]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "density gradient purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(1518"

Phrase: ")."
Processing 00000000.tx.35: At the end of the isolation procedure, the islets were placed in M199 culture medium containing 5.5 mmol/l glucose, cultured in a CO2 incubator, and studied within 34 days from isolation. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the isolation procedure,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0204727:Isolation procedure [Therapeutic or Preventive Procedure]
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "the islets"

Phrase: "were"

Phrase: "placed in M199 culture medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5.5 mmol/l glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "cultured in a CO2 incubator,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021178:Incubator [Manufactured Object]
   760   C2347816:Co2+ [Element, Ion, or Isotope]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "studied within 34 days"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   786   C2826182:Study Day [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "from isolation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.36: View this table: [in this window] [in a new window]  TABLE 1 Main clinical characteristics of type 2 diabetic and nondiabetic donors  Electron microscopy evaluation. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Main clinical characteristics of type 2 diabetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0683325:clinical characteristics [Clinical Attribute]
   745   C3645613:Characteristic type [Intellectual Product]
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "nondiabetic donors  Electron microscopy evaluation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0262458:DONOR EVALUATION [Health Care Activity]
   804   C0220825:Evaluation [Functional Concept]
   804   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.37: Electron microscopy experiments were accomplished with five control and seven type 2 diabetic islet preparations, as previously described (16,18). 

Phrase: "Electron microscopy experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0026019:Electron Microscopy [Laboratory Procedure]
   734   C2984656:ELECTRON MICROSCOPY [Functional Concept]

Phrase: "were"

Phrase: "accomplished with five control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205451:Five [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "seven type 2 diabetic islet preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0455052:Preparation [Health Care Activity]
   766   C1521827:Preparation [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.38: Islets were pelletted by centrifugation at 1,300g and fixed with 2.5% glutaraldehyde in 0.1 mol/l cacodylate buffer, pH 7.4, for 1 h at 4C. 

Phrase: "Islets"

Phrase: "were"

Phrase: "pelletted by centrifugation at 1,"

Phrase: "300g"

Phrase: "and"

Phrase: "fixed with 2.5% glutaraldehyde"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]
   704 E C0878318:Cidex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in 0.1 mol/l cacodylate buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.39: After rinsing in cacodylate buffer, pellets were postfixed in 1% cacodylate-buffered osmium tetroxide for 2 h at room temperature and then dehydrated in a graded series of ethanol, transferred to propylene oxide, and embedded in Epon-Araldite. 

Phrase: "After"

Phrase: "rinsing in cacodylate buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882955:Rinsing [Activity]

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "postfixed in 1% cacodylate-buffered osmium tetroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0029385:Osmium Tetroxide [Hazardous or Poisonous Substance,Inorganic Chemical]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0029383:Osmium [Element, Ion, or Isotope]
   748   C0282083:Cacodylate [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dehydrated in a graded series of ethanol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0001962:Ethanol [Organic Chemical]
   748   C0011175:Dehydrated [Disease or Syndrome]
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "transferred to propylene oxide,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0072229:propylene oxide [Organic Chemical]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0072221:propylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C2986642:oxide [Chemical Viewed Functionally]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "embedded in Epon-Araldite."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0052301:araldite [Organic Chemical,Pharmacologic Substance]
   770   C0059460:EPON [Organic Chemical]
   770   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.40: Ultrathin sections (60- to 80-nm thick) were cut with a diamond knife, placed on formvar carbon-coated copper grids (200 mesh), and stained with uranyl acetate and lead citrate. 

Phrase: "Ultrathin sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "(60-"

Phrase: "to 80-nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cut with a diamond knife,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0481414:knife cut [Injury or Poisoning]
   760   C0000925:Cut [Injury or Poisoning]
   760   C0057717:Diamond [Element, Ion, or Isotope]
   760   C0181467:knife [Medical Device]
   760   C1706313:KNIFE [Manufactured Object]
   760   C1706341:Diamond [Qualitative Concept]
   760   C1883724:CUT [Phenomenon or Process]

Phrase: "placed on formvar carbon-coated copper grids"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   748   C0007009:Carbon [Element, Ion, or Isotope]
   748   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0950318:Formvar [Hazardous or Poisonous Substance,Organic Chemical]
   748   C1522408:Coated [Qualitative Concept]
   748   C2347872:Copper+ [Element, Ion, or Isotope]
   748   C2348263:Copper [Element, Ion, or Isotope]
   714   C0442504:Place [Spatial Concept]
   714 E C0453946:Coat [Manufactured Object]
   714   C1415284:GRID [Gene or Genome]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C2348395:Grid [Medical Device]
   714   C2825313:Grid [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]
   714   C3496241:place [Disease or Syndrome]

Phrase: "(200 mesh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0181805:Mesh [Medical Device]
   861   C1135584:MeSH [Intellectual Product]
   861   C1552983:Mesh [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "stained with uranyl acetate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   865   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   833   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "lead citrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008857:Citrate [Organic Chemical]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.41: Micrographs were obtained at 10,000x. 

Phrase: "Micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   893   C0240341:Micrographia [Finding]
   893   C0596928:micrography [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained at 10,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "000x."
Processing 00000000.tx.42: Every microscopic field was analyzed to count -, -, and -cells, and the respective proportions were expressed as the number of a given endocrine cell type over the total number of endocrine cells x 100. 

Phrase: "Every microscopic field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "count -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the respective proportions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   777 E C0205351:Proportional [Qualitative Concept]

Phrase: "were"

Phrase: "expressed as the number of a given endocrine cell type"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   775   C0449475:Type of cell [Intellectual Product]
           cell type
   760   C0007634:Cell Type [Cell]
           Cell
   760   C0229525:Endocrine cell [Cell]
   757   C0007584:Cell Number [Laboratory Procedure]
   757   C1882124:Number Type [Conceptual Entity]
   739   C0014136:Endocrine [Body System]
   739   C0237753:*Number [Quantitative Concept]
   739   C0332307:Type [Qualitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0521425:Endocrine [Functional Concept]
   739   C1269647:Cell [Cell]
   739   C1547052:*Type [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "over the total number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0237753:*Number [Quantitative Concept]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of endocrine cells x 100."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0229525:Endocrine Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014136:Endocrine [Body System]
   812   C0521425:Endocrine [Functional Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.43: Insulin secretion studies. 

Phrase: "Insulin secretion studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1256369:insulin secretion [Cell Function]
Processing 00000000.tx.44: Insulin secretion studies were performed by the batch incubation method or using a perifusion procedure, as previously described (1518). 

Phrase: "Insulin secretion studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "were"

Phrase: "performed by the batch incubation method"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   753   C1550176:Batch [Idea or Concept]
   753   C1948031:Batch [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a perifusion procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(1518"

Phrase: ")."
Processing 00000000.tx.45: In these experiments (three to five batches at any given experimental condition for each separate islet preparation), after a 45-min preincubation period at 3.3 mmol/l glucose, groups of 30 islets of comparable size were kept at 37C for 45 min in Krebs-Ringer bicarbonate solution (KRB) and 0.5% albumin, pH 7.4, containing 3.3 mmol/l glucose. 

Phrase: "In these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "(three to five batches at any given experimental condition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1550176:Batch [Idea or Concept]
   742   C1948031:Batch [Quantitative Concept]

Phrase: "for each separate islet preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "after"

Phrase: "a 45-min preincubation period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "at 3.3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "groups of 30 islets of comparable size"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0237884:group size [Group Attribute]
   748   C0441833:Group [Idea or Concept]
   748   C0456389:size [Spatial Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "kept at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0333118:Keep [Functional Concept]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in Krebs-Ringer bicarbonate solution (KRB)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   875   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5% albumin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3.3 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.46: At the end of this period, medium was completely removed and replaced with KRB containing either 3.3 mmol/l glucose, 16.7 mmol/l glucose, 3.3 mmol/l glucose plus 20 mmol/l arginine, or 3.3 mmol/l glucose plus 100 mol/l glibenclamide. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of this period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with KRB"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   820   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   791   C1690922:bicarbonated Ringer's solution [Pharmacologic Substance]
   783   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0559956:Replaced [Functional Concept]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C1299987:replaced [Functional Concept]
   753   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 3.3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "16.7 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "3.3 mmol/l glucose plus 100 mol/l glibenclamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.47: After an additional 45-min incubation, medium samples were collected and stored at 20C until insulin concentrations were measured by immunoradiometric assay (Pantec Forniture Biomediche, Turin, Italy). 

Phrase: "After an additional 45-min incubation,"

Phrase: "medium samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured by immunoradiometric assay"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0021073:Immunoradiometric Assay [Laboratory Procedure]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Pantec Forniture Biomediche,"

Phrase: "Turin,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")."
Processing 00000000.tx.48: In the perifusion studies, batches of 50 islets were perifused at 37C (flow rate of 1 ml/min) with 3.3 mmol/l glucose, and then challenged with either 16.7 mmol/l glucose, 3.3 mmol/l glucose plus 20 mmol/l arginine, or 3.3 mmol/l glucose plus 100 mol/l glibenclamide. 

Phrase: "In the perifusion studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "batches of 50 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1550176:Batch [Idea or Concept]
   770   C1948031:Batch [Quantitative Concept]

Phrase: "were"

Phrase: "perifused at 37C"

Phrase: "(flow rate of 1 ml/min)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2826285:Flow Rate [Quantitative Concept]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "with 3.3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with either 16.7 mmol/l glucose,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0439190:MMOLE [Quantitative Concept]
   711   C0798503:Challenge [Clinical Attribute]
   711   C0805586:Challenge [Health Care Activity]
   711   C3274764:Challenge [Conceptual Entity]

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "3.3 mmol/l glucose plus 100 mol/l glibenclamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.49: With the islets prepared from four control and four diabetic pancreata, glucose-stimulated insulin secretion studies were also performed after 24-h pre-exposure to 30 mol/l glutathione (GSH). 

Phrase: "With the islets"

Phrase: "prepared from four control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205450:Four [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "four diabetic pancreata,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   793   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "glucose-stimulated insulin secretion studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "also"

Phrase: "performed after 24-h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pre-exposure to 30 mol/l glutathione"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332152:Pre [Temporal Concept]
   748   C0740175:Pre [Qualitative Concept]
   748   C2257086:PRE [Genetic Function]

Phrase: "(GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.50: At the end of these experiments, islets were pelletted and stored at 130C until measurement of GSH and GSH disulfide (GSSG) was performed by a GSH assay kit (Cayman Chemical, Ann Arbor, MI). 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "islets"

Phrase: "were"

Phrase: "pelletted"

Phrase: "and"

Phrase: "stored at 130C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "GSH disulfide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012771:disulfide [Chemical Viewed Structurally]
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: "(GSSG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061516:GSSG [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "performed by a GSH assay kit (Cayman Chemical, Ann Arbor,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   760   C1550369:Performed By [Qualitative Concept]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0079078:Caiman [Reptile]
   739   C0220806:Chemical [Chemical]
   739   C0243073:assay [Qualitative Concept]
   739   C0812225:KIT [Medical Device]
   739   C0884358:Performed [Functional Concept]
   739   C1150635:KIT [Molecular Function]
   739   C1260386:GSH [Disease or Syndrome]
   739   C1510438:Assay [Laboratory Procedure]
   739   C1705212:Kit [Medical Device]
   739   C1705213:KIT [Medical Device]
   739   C3272558:Chemical [Intellectual Product]
   739   C3273202:Kit [Manufactured Object]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "MI)."
Processing 00000000.tx.51: Glucose oxidation experiments. 

Phrase: "Glucose oxidation experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.52: Glucose oxidation was assessed by measuring the formation of 14CO2 from [U-14C]glucose, as previously described (19,20). 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "assessed by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C1516048:Assessed [Activity]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the formation of 14CO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "from"

Phrase: "[U-14C"

Phrase: "]glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.53: Groups of 15 islets were incubated in a plastic cup in 100 l of KRB containing 3 Ci D-[U-14C]glucose (specific activity 302 mCi/mmol) plus nonradioactive glucose to a final concentration of either 3.3 or 16.7 mmol/l. 

Phrase: "Groups of 15 islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "incubated in a plastic cup"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032167:Plastic [Substance]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1533124:Cup [Medical Device]
   760   C1552944:cup [Quantitative Concept]
   760   C2949743:Cup [Manufactured Object]

Phrase: "in 100 l"

Phrase: "of KRB"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   875   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3 Ci"

Phrase: "D-["

Phrase: "U-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(specific activity 302 mCi/mmol) plus nonradioactive glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of either 3.3"

Phrase: "or"

Phrase: "16.7 mmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.54: The cups, which were suspended in standard 20-ml glass scintillation vials, were gassed with O2:CO2 (95:5%) and were capped airtight. 

Phrase: "The cups,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0180231:CUPS [Medical Device]
   966 E C1533124:Cup [Medical Device]
   966 E C1552944:cup [Quantitative Concept]
   966 E C2949743:Cup [Manufactured Object]

Phrase: "which"

Phrase: "were"

Phrase: "suspended in standard 20-ml glass scintillation vials,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   750   C1708244:Glass Vial [Manufactured Object]
   744   C0017596:Glass [Manufactured Object]
   744   C0184301:vials [Medical Device]
   744   C0439526:/mL [Quantitative Concept]
   744   C0678573:scintillation [Natural Phenomenon or Process]
   744   C1442989:Standard [Qualitative Concept]
   744   C1533199:Vials [Quantitative Concept]
   744   C1553389:suspended [Idea or Concept]
   744   C1553403:suspended [Idea or Concept]
   744   C1705537:Suspended [Functional Concept]
   744   C1947936:Glass [Medical Device]
   744   C2828392:Standard [Intellectual Product]
   711 E C1706497:VIAL [Medical Device]

Phrase: "were"

Phrase: "gassed with O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   756   C0017110:Gas [Chemical Viewed Structurally]
   756   C0596601:Gas [Sign or Symptom]

Phrase: ":"

Phrase: "CO2 (95"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "capped"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0179586:Cap [Manufactured Object]
   966   C1657858:CAP [Medical Device]
   966   C1706092:Cap [Medical Device]

Phrase: "airtight."
Processing 00000000.tx.55: The vials were then shaken continuously at 37C for 120 min. 

Phrase: "The vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "shaken"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0040822:shake [Sign or Symptom]
   966   C1883023:Shake [Activity]

Phrase: "continuously at 37C"

Phrase: "for 120 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.56: The islets metabolism was stopped by injecting 100 l of 0.05 mmol/l antimycin A (dissolved in 70% ethanol) into the cups. 

Phrase: "The islets metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "stopped by injecting 100 l of 0.05 mmol/l antimycin A"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   751   C1532563:mmol/L [Quantitative Concept]
   736   C0052078:antimycin [Antibiotic,Organic Chemical]
   736   C0439190:MMOLE [Quantitative Concept]
   736   C1272691:stopped [Qualitative Concept]
   703   C1720154:Inject [Functional Concept]
   703 E C1947925:Stop [Activity]
   703 E C2746065:Stop [Temporal Concept]

Phrase: "("

Phrase: "dissolved in 70% ethanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1381542:70% Ethanol [Clinical Drug]
   770   C0001962:Ethanol [Organic Chemical]
   737   C1549535:Dissolve [Functional Concept]

Phrase: ")"

Phrase: "into the cups."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0180231:CUPS [Medical Device]
   966 E C1533124:Cup [Medical Device]
   966 E C1552944:cup [Quantitative Concept]
   966 E C2949743:Cup [Manufactured Object]
Processing 00000000.tx.57: This was immediately followed by an injection of 20 l hyamine hydroxide (Sigma) into the vials. 

Phrase: "This"

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "followed by an injection of 20 l hyamine hydroxide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0332283:Followed by [Temporal Concept]
           followed
   742   C0021485:injection [Therapeutic or Preventive Procedure]
   742   C0220853:hydroxide [Element, Ion, or Isotope]
   742   C0888480:Hyamine [Organic Chemical,Pharmacologic Substance]
   742   C1272883:Injection [Biomedical or Dental Material]
   742   C1533685:Injection [Therapeutic or Preventive Procedure]
   742   C1828121:Injection [Functional Concept]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "into the vials."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]
Processing 00000000.tx.58: 14CO2 was liberated from the incubation medium by a subsequent injection into the cup of 100 l 0.4 mmol/l Na2HPO4 solution adjusted to a pH of 6.0. 

Phrase: "14CO2"

Phrase: "was"

Phrase: "liberated from the incubation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "by a subsequent injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "into the cup"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1533124:Cup [Medical Device]
  1000   C1552944:cup [Quantitative Concept]
  1000   C2949743:Cup [Manufactured Object]

Phrase: "of 100 l 0.4 mmol/l Na2HPO4 solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0037633:Solution [Substance]
   793   C0525069:Solution [Biomedical or Dental Material]

Phrase: "adjusted to a pH of 6.0."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020283:[pH] [Quantitative Concept]
   748   C0450407:ph+ [Finding]
   748   C0450408:ph++ [Finding]
   748   C0450409:ph+++ [Finding]
   748   C0456081:Adjusted [Functional Concept]
Processing 00000000.tx.59: After 2 h at room temperature (to allow the liberated 14CO2 to be trapped by the hyamine hydroxide), the cup was removed, and 10 ml of a scintillation fluid was added to each vial. 

Phrase: "After 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the liberated 14CO2 to"

Phrase: "be"

Phrase: "trapped by the hyamine hydroxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0184047:Trapped [Medical Device]
   760   C0220853:hydroxide [Element, Ion, or Isotope]
   760   C0888480:Hyamine [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "the cup"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1533124:Cup [Medical Device]
  1000   C1552944:cup [Quantitative Concept]
  1000   C2949743:Cup [Manufactured Object]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "10 ml of a scintillation fluid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to each vial."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0184301:Phial [Medical Device]
   770   C1524062:Added [Functional Concept]
   770   C1533199:Vial [Quantitative Concept]
   770   C1706497:VIAL [Medical Device]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.60: Radioactivity was measured in a liquid scintillation counter. 

Phrase: "Radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured in a liquid scintillation counter."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0036405:Scintillation Counter [Medical Device]
   790   C1710025:Scintillation Counter [Manufactured Object]
   753   C0302908:Liquid [Substance]
   753   C0444706:Measured [Qualitative Concept]
   753   C0677601:Counter [Manufactured Object]
   753   C0678573:scintillation [Natural Phenomenon or Process]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1705206:Counter [Medical Device]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.61: PCR studies. 

Phrase: "PCR studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.62: Messenger RNA expression of several genes was measured by real-time quantitative RT-PCR (21). 

Phrase: "Messenger RNA expression of several genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040649:RNA Expression [Genetic Function]
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured by real-time quantitative RT-PCR"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.63: Total RNA was extracted from human pancreatic islets using an RNeasy Protect Mini Kit (Qiagen, Valencia, CA) and quantified by absorbance at A260/A280 (ratio >1.65) nm in a Perkin-Elmer spectrophotometer. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from human pancreatic islets"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an RNeasy"

Phrase: "Protect"

Phrase: "Mini Kit (Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "quantified by absorbance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "at A260/A280"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706689:A280 [Molecular Biology Research Technique]

Phrase: "(ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: ">1.65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450385:65 [Intellectual Product]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "nm in a Perkin-Elmer spectrophotometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.64: Integrity was assessed after electrophoresis in 1.0% agarose gels by ethidium bromide staining. 

Phrase: "Integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "assessed after electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "in 1.0% agarose gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C1706746:Agarose Gel [Research Device]
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "by ethidium bromide staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.65: cDNA synthesis was performed from 2 g of total RNA, and the oligonucleotides of interest were obtained from assay-on-demand gene expression products (Applied Biosystem). 

Phrase: "cDNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "performed from 2 g of total RNA,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439175:% total [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "the oligonucleotides of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from assay-on-demand gene expression products"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0017262:Gene Expression [Genetic Function]
   750   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0441516:Demand [Therapeutic or Preventive Procedure]
   744   C0699784:demand [Idea or Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "(Applied Biosystem"

Phrase: ")."
Processing 00000000.tx.66: To avoid amplification of genomic DNA, the primers were designed to span exon-exon borders. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "amplification of genomic DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0683230:DNA amplification [Genetic Function]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "exon-exon borders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205284:Border [Spatial Concept]
   827   C1522411:Border [Body Location or Region]
   827   C2828371:Border [Classification]
Processing 00000000.tx.67: The probes were labeled with FAM at the 5' end and TAMRA at the 3' end. 

Phrase: "The probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "labeled with FAM"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708632:Labeled [Qualitative Concept]
   790   C3541878:FAM [Gene or Genome]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at the 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "TAMRA at the 3' end."
Processing 00000000.tx.68: PCR amplification (40 cycles) was performed in a total volume of 25 l containing 1 l cDNA sample, 200 nmol/l of each primer, 100 nmol/l of the corresponding probe, and 12.5 l of TaqMan Universal PCR Master Mix. 

Phrase: "PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(40 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "performed in a total volume of 25 l"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0449468:Total Volume [Quantitative Concept]
           *Volume
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 l cDNA sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]

Phrase: "200 nmol/l of each primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439282:nmol/L [Quantitative Concept]

Phrase: "100 nmol/l of the corresponding probe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0439282:nmol/L [Quantitative Concept]

Phrase: "and"

Phrase: "12.5 l of TaqMan Universal PCR Master Mix."
Processing 00000000.tx.69: Polymerase was activated by preincubation at 95C for 10 min. 

Phrase: "Polymerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "activated by preincubation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "at 95C"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.70: The messenger mRNA level of target genes was quantified and normalized for -actin as previously described (21). 

Phrase: "The messenger mRNA level of target genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "normalized for -actin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1882115:Normalized [Research Activity]
   718 E C0439681:Actinic [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.71: AMP-activated protein kinase protein expression evaluation. 

Phrase: "AMP-activated protein kinase protein expression evaluation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0220825:Evaluation [Functional Concept]
   795   C1261322:Evaluation [Health Care Activity]
   710   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.72: The procedure was performed as published previously (22,23) and slightly modified to be applied to human islets. 

Phrase: "The procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "previously"

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "applied to human islets."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.73: Islet cell lysate aliquots containing 200 g protein were immunoprecipitated by incubation with total (anti-AMP-activated protein kinase- [AMPK-]) and activated (phospho-AMPK-, Thr172) protein antibodies (Cell Signaling Technologies, Beverly, MA). 

Phrase: "Islet cell lysate aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "with total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "(anti-AMP-activated protein kinase-"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   875   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(phospho-AMPK-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "Thr172"

Phrase: ")"

Phrase: "protein antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Cell Signaling Technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: "Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.74: After immunoprecipitation, bound antibodies were detected using procedures performed according to the manufacturers instructions (enhanced chemiluminescence; Amersham Biosciences, Buckinghamshire, U.K.). 

Phrase: "After immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "performed according to the manufacturers instructions"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C1442085:Instructions [Idea or Concept]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719   C0947322:Manufacturer [Intellectual Product]
   719   C1705426:Manufacturer [Population Group]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "; Amersham Biosciences,"

Phrase: "Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.75: Bands of interest were quantified by a densitometer (GS 690; Bio-Rad, Hercules, CA), using MultiAnalyst/PC-PC Software for image analysis systems, version 1.02 (Bio-Rad). 

Phrase: "Bands of interest"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0175723:Bands [Medical Device]
   756 E C0439645:Band [Spatial Concept]
   756 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantified by a densitometer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0180321:Densitometer [Medical Device]
   770   C1706216:Densitometer [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "(GS 690"

Phrase: "; Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA),"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MultiAnalyst/PC-PC Software for image analysis systems,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "version 1.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.76: Determination of islet cell nitrotyrosine concentration. 

Phrase: "Determination of islet cell nitrotyrosine concentration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.77: Nitrotyrosine concentration was determined in islet cell lysates by an enzyme-linked immunosorbent assay method as previously described (24,25). 

Phrase: "Nitrotyrosine concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined in islet cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   806   C1522529:Islet Cell [Cell]
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "by an enzyme-linked immunosorbent assay method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C0450074:Enzyme method [Intellectual Product]
   853   C1532280:Immunosorbent method [Laboratory Procedure]
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   708   C2717977:Enzyme Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.78: White 96-well plates (Iwaki, Chiba, Japan) were coated with 200 l of standard curve samples (range of concentrations 0.16615 nmol/l) or 1 g/l of islet cell lysates (65 l/well) in 0.1 mol/l carbonate-bicarbonate buffer (135 l), pH 9.6, and kept overnight at 4C. 

Phrase: "White 96-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007457:White [Population Group]
   827   C0043157:White [Population Group]
   827   C0205170:Well [Qualitative Concept]
   827   C0220938:White [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(Iwaki,"

Phrase: "Chiba,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "coated with 200 l of standard curve samples"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0205134:Curve [Spatial Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1522408:Coated [Qualitative Concept]
   744   C2828392:Standard [Intellectual Product]
   711   C0370003:Sample [Substance]
   711 E C0453946:Coat [Manufactured Object]
   711   C2347026:Sample [Conceptual Entity]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(range of concentrations 0.16615 nmol/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "or"

Phrase: "1 g/l of islet cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0439294:g l [Quantitative Concept]
   774   C0022827:cell l [Cell]

Phrase: "(65 l/well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0450385:65 [Intellectual Product]
   827   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "in 0.1 mol/l carbonate-bicarbonate buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0973231:Bicarbonate [Inorganic Chemical]
   795   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(135 l), pH 9.6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.79: Nonspecific binding was blocked by 1% BSA in PBS plus 0.05% Tween 20 for 1 h at 37C, and the wells were incubated with purified monoclonal anti-nitrotyrosine mouse IgG (Upstate, Lake Placid, NY) for 1 h at 37C. 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked by 1% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS plus 0.05% Tween 20"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   799 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   799   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   799   C0332287:Plus [Qualitative Concept]
   799   C1720830:PBS [Disease or Syndrome]
   799   C1823521:PBS [Gene or Genome]
   743 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "incubated with purified monoclonal anti-nitrotyrosine mouse IgG (Upstate,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0946139:IgG.monoclonal [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   742   C0746619:monoclonal [Finding]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1998793:Purified [Functional Concept]

Phrase: "Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.80: Then, the plates were washed and incubated with a peroxidase-conjugated goat anti-mouse IgG secondary antibody for 45 min at 37C. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "incubated with a peroxidase-conjugated goat anti-mouse IgG secondary antibody"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C2754943:IgG antibody [Cell Component]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0018019:goat [Mammal]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   738   C0025914:Mouse [Mammal]
   738   C0025929:mouse [Mammal]
   738   C0026809:Mouse [Mammal]
   738   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0027627:secondary [Neoplastic Process]
   738   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0175668:Secondary [Temporal Concept]
   738   C0205436:Secondary [Quantitative Concept]
   738   C0522529:Conjugated [Spatial Concept]
   738   C1265549:goat [Mammal]
   738   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1510458:Goat [Mammal]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.81: The peroxidase reaction product was generated using TMB (tetramethyl-benzidine) microwell peroxidase substrate (150 l/well; Sigma-Aldrich). 

Phrase: "The peroxidase reaction product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]
   734   C1151518:peroxidase reaction [Molecular Function]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TMB"

Phrase: "(tetramethyl-benzidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0046880:Tetramethylbenzidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0005047:benzidine [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "microwell peroxidase substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "(150 l/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "; Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.82: Plates were incubated 510 min at room temperature, and optical density was read at 492 nm in a microplate reader. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "510 min at room temperature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "read at 492 nm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034754:Read [Daily or Recreational Activity]
   770   C0312860:NM [Cell Function]
   770   C1705179:read [Finding]

Phrase: "in a microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.83: Determination of islet cell 8-hydroxy-2'-deoxyguanosine concentration. 

Phrase: "Determination of islet cell 8-hydroxy-2'-deoxyguanosine concentration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.84: The 8-hydroxy-2'-deoxyguanosine (8-OHdG) amount was determined in human pancreatic islet DNA digests, using a Bioxytech 8-OHdG-EIA kit, a competitive enzyme-linked immunosorbent assay purchased from OXIS Health Products (Portland, OR) (25,26). 

Phrase: "The 8-hydroxy-2'-deoxyguanosine (8-OHdG) amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1265611:Amount [Quantitative Concept]
   771   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "determined in human pancreatic islet DNA digests,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0868946:Digests [Physiologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bioxytech 8-OHdG-EIA kit,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0812225:KIT [Medical Device]
   795   C1150635:KIT [Molecular Function]
   795   C1705212:Kit [Medical Device]
   795   C1705213:KIT [Medical Device]
   795   C3273202:Kit [Manufactured Object]
   710   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a competitive enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   937   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   875   C2717977:Enzyme Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   771   C1517892:Link [Intellectual Product]
   771   C1704666:Link [Intellectual Product]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "purchased from OXIS Health Products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0018684:Health [Idea or Concept]
   760   C0595397:Oxis [Organic Chemical,Pharmacologic Substance]
   760   C0869011:purchased [Activity]
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "(Portland,"

Phrase: "OR) (25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.85: All analyses and calibrations (range of 0.5200 ng/ml) were performed in duplicate. 

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "calibrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006751:Calibrations [Quantitative Concept]

Phrase: "(range of 0.5200 ng/ml)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.86: Total DNA was extracted using a Wizard SV Genomic DNA purification system (Promega) and then quantified by absorbance at A260/A280 (ratio >1.65) nm in a Perkin-Elmer spectrophotometer. 

Phrase: "Total DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Wizard SV Genomic DNA purification system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "quantified by absorbance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "at A260/A280"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706689:A280 [Molecular Biology Research Technique]

Phrase: "(ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: ">1.65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450385:65 [Intellectual Product]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "nm in a Perkin-Elmer spectrophotometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.87: Samples containing 200 g of DNA were resuspended in 50 l of reaction mixture containing 100 mmol/l sodium acetate, pH 5.0, and 5 mmol/l MgCl2, and then they were digested with 1 l DNase I (QIAGEN) for 10 min at room temperature. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 g of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 50 l of reaction mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439962:Mixture [Substance]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mmol/l sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 5.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "5 mmol/l MgCl2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "they"

Phrase: "were"

Phrase: "digested with 1 l DNase I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   790   C1148702:DNase I [Genetic Function]
   783   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   783   C1425233:I-1 [Gene or Genome]
   783   C3540559:I-1 [Gene or Genome]
   753   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0868946:digested [Physiologic Function]

Phrase: "(QIAGEN"

Phrase: ")"

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.88: 8-OHdG monoclonal antibody and the standard or DNA-digested samples were added to a microtiter plate well that had been precoated with 8-OhdG antibody. 

Phrase: "8-OHdG monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0746619:monoclonal [Finding]
   734   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "or"

Phrase: "DNA-digested samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "added to a microtiter plate well"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1709027:Microtiter Plate [Research Device]
   753   C0005971:Plate [Medical Device]
   753   C0205170:Well [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C1524062:Added [Functional Concept]
   753   C3146287:Well [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]
   719 E C1883712:Add [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "precoated with 8-OhdG antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0050078:8-OHdG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.89: The optical density was determined with a microplate reader at 450 nm. 

Phrase: "The optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "determined with a microplate reader"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0182258:Microplate Reader [Medical Device]
   760   C1514743:Reader [Professional or Occupational Group]
   760   C1706461:Reader [Manufactured Object]
   760   C1709027:Microplate [Research Device]

Phrase: "at 450 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.90: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.91: Results are expressed as the means  SD. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the means  SD."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.92: For any given experiment, results from each pancreas were averaged, and n indicated the number of pancreata used in that specific setting (see RESULTS). 

Phrase: "For any given experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "results from each pancreas"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C1274040:Result [Functional Concept]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "n"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the number of pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "used in that specific setting"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0542559:setting [Functional Concept]
   760   C1273517:used [Finding]
   760   C1318139:{Setting} [Quantitative Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: ")."
Processing 00000000.tx.93: Comparison between groups was performed by two-tailed unpaired Students t test. 

Phrase: "Comparison between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "performed by two-tailed unpaired Students t test."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   793   C1710574:Unpaired t-Test [Intellectual Product]
   770   C1550369:Performed By [Qualitative Concept]
   744   C0022885:Test [Laboratory Procedure]
   744   C0038492:Students [Professional or Occupational Group]
   744   C0039259:tailed [Body Part, Organ, or Organ Component]
   744   C0039593:Test [Functional Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0392366:test [Intellectual Product]
   744   C0884358:Performed [Functional Concept]
   744   C2700112:Unpaired [Qualitative Concept]
   711 E C1551041:student [Idea or Concept]
   711 E C1552573:student [Intellectual Product]
   711 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.94: Unilinear regression analysis was used to correlate insulin secretion and oxidative stress markers.  

Phrase: "Unilinear regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "oxidative stress markers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0005516:Marker [Clinical Attribute]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.95: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Electron microscopy. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Electron microscopy."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.96: The -, -, and -cells in the isolated islets were recognized by the typical ultrastructural appearance, and their relative amounts are reported in Fig. 

Phrase: "The -, -"

Phrase: ","

Phrase: "and -"

Phrase: "cells in the isolated islets"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   797   C0022131:cells islets [Body Part, Organ, or Organ Component]
   764 E C1522529:Islet Cell [Cell]
   762   C0007616:cells isolation [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "recognized by the typical ultrastructural appearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]
   753   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "their relative amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "reported in Fig."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0349966:Fig [Food]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1337208:FIG [Food]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.97: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.98: The proportion of -cells was 68.6  3.0 and 61.7  3.7% in control and type 2 diabetic islets, respectively (P < 0.05). 

Phrase: "The proportion of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "68.6  3.0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450387:68 [Intellectual Product]

Phrase: "and"

Phrase: "61.7  3.7% in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic islets,"

Phrase: "respectively"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.99: No statistically significant difference was observed in the percentages of the other islet endocrine cells, although a trend toward increased proportion of - and -cells was found in the diabetic group (Fig. 1). 

Phrase: "No statistically significant difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]
   734   C0237881:statistically significant [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the percentages of the"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1441672:Observed [Functional Concept]
   719   C0439165:Percentage [Quantitative Concept]
   719   C1549488:Percentage [Idea or Concept]
   719   C1561533:Percentage [Idea or Concept]

Phrase: "other islet endocrine cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   901   C0229525:Endocrine Cells [Cell]
   896 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0014136:Endocrine [Body System]
   827   C0521425:Endocrine [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "a trend toward increased proportion of -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "and -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "found in the diabetic group"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0150312:Found [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0243095:Find [Finding]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.100: View larger version (47K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.102: Endocrine cell composition of control (n = 5) and type 2 diabetic (T2DM; n = 7) islets. 

Phrase: "Endocrine cell composition of control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0486616:Composition [Clinical Attribute]
   760   C1555710:composition [Idea or Concept]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "type 2 diabetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(T2DM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "; n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.103: Bars represent percentage values, and the bottom microphotographs are representative images of -, -, and -cells, recognized by their characteristic granules on electron microscopy examination. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "percentage values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the bottom microphotographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0026009:Microphotography [Laboratory Procedure]

Phrase: "are"

Phrase: "representative images of -, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1704254:Image [Intellectual Product]
   756   C1704922:Image [Entity]
   756   C3542466:Image [Intellectual Product]

Phrase: ","

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "recognized by their characteristic granules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010837:Granules [Cell Component]
   760   C0993609:Granules [Biomedical or Dental Material]
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "on electron microscopy examination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0026018:Microscopic examination [Laboratory Procedure]
   734   C0026019:Electron Microscopy [Laboratory Procedure]
   734   C2984656:ELECTRON MICROSCOPY [Functional Concept]
Processing 00000000.tx.104: N, nucleus; 

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: ";"
Processing 00000000.tx.105: IG, insulin granules; 

Phrase: "IG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3541296:IG [Idea or Concept]

Phrase: "insulin granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.106: GG, glucagon granules; 

Phrase: "GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018370:GG [Geographic Area]

Phrase: "glucagon granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.107: SG, somatostatin granules. 

Phrase: "SG,"

Phrase: "somatostatin granules."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.108: *P < 0.05 vs. control islets.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control islets."
Processing 00000000.tx.109: Insulin secretion. 

Phrase: "Insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.110: Insulin secretion in response to glucose, arginine, and glibenclamide was studied in control and type 2 diabetic islets, and the results are detailed in Table 2. 

Phrase: "Insulin secretion in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "studied in control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "type 2 diabetic islets,"

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "detailed in Table 2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1522508:Detailed [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C1561567:detail [Functional Concept]
Processing 00000000.tx.111: No significant difference between control and type 2 diabetic islets was observed for insulin release in response to 3.3 mmol/l glucose. 

Phrase: "No significant difference between control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic islets"

Phrase: "was"

Phrase: "observed for insulin release"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to 3.3 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.112: However, when challenged with 16.7 mmol/l glucose, diabetic islets secreted significantly less insulin than nondiabetic cells (Table 2). 

Phrase: "However,"

Phrase: "when"

Phrase: "challenged with 16.7 mmol/l glucose,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0439190:MMOLE [Quantitative Concept]
   714   C0798503:Challenge [Clinical Attribute]
   714   C0805586:Challenge [Health Care Activity]
   714   C3274764:Challenge [Conceptual Entity]

Phrase: "diabetic islets"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "significantly less insulin than nondiabetic cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: Insulin secretion during arginine and glibenclamide stimulation was also lower from diabetic islets than from control islets (Table 2). 

Phrase: "Insulin secretion during arginine"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   819   C1955116:Arginine+Insulin [Laboratory Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "also lower from diabetic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "from control islets"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: However, type 2 diabetic islets released a significantly higher amount of insulin in response to arginine and glibenclamide than in response to glucose (Table 2). 

Phrase: "However,"

Phrase: "type 2 diabetic islets"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a significantly higher amount of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: Accordingly, when insulin secretion was calculated as the ratio of stimulated release to basal release (stimulation index), the values with diabetic and control islets were, respectively, 1.2  0.4 and 2.2  0.8 in response to glucose (P < 0.01), 1.7  0.5 and 2.3  0.4 in response to arginine (P < 0.01), and 1.8  0.5 and 2.3  0.7 in response to glibenclamide (P < 0.05). 

Phrase: "Accordingly,"

Phrase: "when"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "calculated as the ratio of stimulated release"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1547037:Ratio [Intellectual Product]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to basal release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(stimulation index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0918012:Index [Intellectual Product]
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "the values with diabetic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "control islets"

Phrase: "were"

Phrase: ","

Phrase: "respectively,"

Phrase: "1.2  0.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0580272:1/2 [Intellectual Product]
   861   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.2  0.8 in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0740116:+2 [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2827735:2+ [Quantitative Concept]
   753   C2911692:Response [Mental Process]
   753   C2981700:2+ [Classification]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "1.7  0.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0450316:1/5 [Quantitative Concept]
   861   C0444499:0/5 [Quantitative Concept]
   861   C3541329:1-7 [Gene or Genome]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.3  0.4 in response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1519042:2-3 [Research Activity]
   753   C0740116:+2 [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2827735:2+ [Quantitative Concept]
   753   C2911692:Response [Mental Process]
   753   C2981700:2+ [Classification]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1.8  0.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0450316:1/5 [Quantitative Concept]
   861   C0444499:0/5 [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.3  0.7 in response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1519042:2-3 [Research Activity]
   753   C0740116:+2 [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2827735:2+ [Quantitative Concept]
   753   C2911692:Response [Mental Process]
   753   C2981700:2+ [Classification]

Phrase: "to glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.116: Again, a less marked impairment of insulin secretion as induced by nonglucose stimuli in diabetic islets was shown because stimulation indexes of diabetic islets in response to arginine and glibenclamide were significantly higher (P < 0.01) than in response to glucose. 

Phrase: "Again,"

Phrase: "a less marked impairment of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "as"

Phrase: "induced by nonglucose stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0234402:Stimuli [Phenomenon or Process]

Phrase: "in diabetic islets"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "because"

Phrase: "stimulation indexes of diabetic islets"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0600653:Indexes [Intellectual Product]
   760   C0918012:indexes [Intellectual Product]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   726 E C1552854:index [Idea or Concept]
   726 E C1637833:% index [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.117: View this table: [in this window] [in a new window]  TABLE 2 Insulin secretion results (U  islet1  45 min1) from control and type 2 diabetic islets in response to 3.3 mmol/l glucose, 16.7 mmol/l glucose, 3.3 mmol/l glucose plus 20 mmol/l arginine, or 3.3 mmol/l glucose plus 100 mol/l glibenclamide  In type 2 diabetic patients, a defect of the early phase of insulin release has been consistently reported both in vitro and in vivo (8,14,27). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Insulin secretion results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1274040:Result [Functional Concept]
   771   C1546471:Result [Idea or Concept]
   771   C2825142:Result [Finding]

Phrase: "(U  islet1  45 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3272448:MIN1 [Gene or Genome]

Phrase: ")"

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic islets in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1425576:ISLET 2 [Gene or Genome]

Phrase: "to 3.3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "16.7 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "3.3 mmol/l glucose plus 100 mol/l glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "In type 2 diabetic patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "a defect of the early phase of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1457869:Defect [Functional Concept]
   742   C1861101:DEFECT [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "consistently"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(8,"

Phrase: "14,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.118: We studied this issue with isolated type 2 diabetic islets, and the results are reported in Fig. 

Phrase: "We"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "this issue with isolated type 2 diabetic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033213:Issue [Finding]
   744   C1706387:Issue [Intellectual Product]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "reported in Fig."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0349966:Fig [Food]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1337208:FIG [Food]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.119: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.120: Glucose stimulation did not elicit any apparent increase of the early insulin secretion phase from diabetic islets (Fig. 2). 

Phrase: "Glucose stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "any apparent increase of the early insulin secretion phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0020459:INSULIN INCREASE [Disease or Syndrome]
   742   C0442805:Increase [Functional Concept]

Phrase: "from diabetic islets"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: However, when challenged with arginine or sulfonylurea, type 2 diabetic islets promptly released insulin, similar to that observed with control islets (Fig. 2). 

Phrase: "However,"

Phrase: "when"

Phrase: "challenged with arginine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "sulfonylurea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
  1000   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "type 2 diabetic islets promptly released insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0421248:diabetic insulin [Finding]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed with control islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.122: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.124: Insulin secretion from type 2 diabetic islets during perifusion experiments. 

Phrase: "Insulin secretion from type 2 diabetic islets"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1256369:insulin secretion [Cell Function]
   774   C0421248:diabetic insulin [Finding]
   774   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "during perifusion experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.125: For these experiments, 50 islets from five separate preparations were placed in a perifusion chamber and perifused with 3.3 mmol/l glucose solution for 30 min, and then (arrow) with either 16.7 mmol/l glucose (16.7 G), 3.3 mmol/l glucose plus 20 mmol/l arginine (Arginine), or 3.3 mmol/l glucose plus 100 mol/l glibenclamide (Glibenclamide). 

Phrase: "For these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "50 islets from five separate preparations"

Phrase: "were"

Phrase: "placed in a perifusion chamber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "perifused with 3.3 mmol/l glucose solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0037633:Solution [Substance]
   744   C0439190:MMOLE [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "with either 16.7 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(16.7 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "3.3 mmol/l glucose plus 100 mol/l glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(Glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.126: The flow rate was 1 ml/min, and samples were collected every minute. 

Phrase: "The flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "1 ml/min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439445:mL/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every minute."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.127: Compared with control islets (A), type 2 diabetic islets (B) did not show any apparent increase of early insulin secretion during 16.7 mmol/l glucose, whereas 3.3 mmol/l glucose plus 20 mmol/l arginine and 3.3 mmol/l glucose plus 100 mol/l glibenclamide elicited a peak of insulin release. 

Phrase: "Compared with control islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "type 2 diabetic islets"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any apparent increase of early insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "during 16.7 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "3.3 mmol/l glucose plus 20 mmol/l arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "3.3 mmol/l glucose plus 100 mol/l glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "a peak of insulin release."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]
Processing 00000000.tx.128: *P < 0.05 of 16.7 mmol/l glucose vs. the other experimental conditions.  

Phrase: "*P < 0.05 of 16.7 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "the other experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.129: Intracellular glucose handling. 

Phrase: "Intracellular glucose handling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018578:Handling [Behavior]
   827   C1832073:Handling [Finding]
Processing 00000000.tx.130: To investigate the possible mechanisms leading to defects in glucose-stimulated insulin secretion, several steps involved in intracellular glucose handling were explored. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possible mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to defects"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0243067:defects [Functional Concept]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in glucose-stimulated insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "several steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "involved in intracellular glucose handling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0018578:Handling [Behavior]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1832073:Handling [Finding]

Phrase: "were"

Phrase: "explored."
Processing 00000000.tx.131: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.132: 3, mRNA expression of GLUT1 and -2 and glucokinase was reduced in type 2 diabetic islets, whereas no difference was observed in the expression of phosphofructokinase, aldolase, and pyruvate kinase. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "mRNA expression of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515670:mRNA Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "was"

Phrase: "reduced in type 2 diabetic islets,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed in the expression of phosphofructokinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031651:Phosphofructokinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0162449:PHOSPHOFRUCTOKINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "aldolase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016762:Aldolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pyruvate kinase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.133: In addition, it was found that at 3.3 mmol/l glucose, there was no significant difference between diabetic and control islets in the rate of glucose oxidation (Table 3), whereas at a high exose level, glucose oxidation was significantly lower in diabetic than in nondiabetic cells (Table 3). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that at 3.3 mmol/l glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0439190:MMOLE [Quantitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference between diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control islets in the rate of glucose oxidation"

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas at a high exose level,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299351:High [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2700149:HIGH [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "significantly lower in diabetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in nondiabetic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: Thus, the alterations of glucose-induced insulin release from type 2 diabetic islets were accompanied by changes in gene expression of molecules involved in glucose transport and metabolism and by reduced glucose oxidation. 

Phrase: "Thus,"

Phrase: "the alterations of glucose-induced insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "from type 2 diabetic islets"

Phrase: "were"

Phrase: "accompanied by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved in glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1314939:Involved [Functional Concept]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and by reduced glucose oxidation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0030011:Oxidation [Molecular Function]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.135: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.137: Quantitative PCR experiments to show mRNA expression of GLUT1 and -2, glucokinase (GK), phosphofructokinase (PPK), aldolase, and pyruvate kinase (PK) in control and type 2 diabetic islets. 

Phrase: "Quantitative PCR experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mRNA expression of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515670:mRNA Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "glucokinase (GK),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "phosphofructokinase (PPK),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031651:Phosphofructokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0162449:PHOSPHOFRUCTOKINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "aldolase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016762:Aldolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "pyruvate kinase (PK) in control"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0034348:Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0034354:pyruvate [Organic Chemical]
   770   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "type 2 diabetic islets."
Processing 00000000.tx.138: Bars represent mean and standard deviation values of eight separate experiments with either control or diabetic islets. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard deviation values of eight separate experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "with either control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "diabetic islets."
Processing 00000000.tx.139: *P < 0.05 vs. control. 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.140: , control; 

Phrase: ", control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.141: , type 2 diabetic.  

Phrase: ", type 2 diabetic."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.142: View this table: [in this window] [in a new window]  TABLE 3 Glucose oxidation (pmol/l  islet1  120 min1) in control and type 2 diabetic islets (5 separate preparations each)  The role of AMPK and of some transcription factors. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3 Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030011:Oxidation [Molecular Function]

Phrase: "(pmol/l  islet1  120 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3272448:MIN1 [Gene or Genome]

Phrase: ")"

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic islets"

Phrase: "(5 separate preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "each"

Phrase: ")"

Phrase: "The role of AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and of some transcription factors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Transcription [Genetic Function]
   760   C1515981:And [Idea or Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.143: Because AMPK can modulate several intracellular metabolic pathways and may have a role in the regulation of insulin secretion (23,28), its protein expression and activation was evaluated in control and diabetic islets. 

Phrase: "Because"

Phrase: "AMPK"

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "several intracellular metabolic pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1291081:Metabolic Pathways [Functional Concept]
   812   C0311400:Metabolic [Functional Concept]
   812   C1524026:Metabolic [Cell Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   812   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "may"

Phrase: "have"

Phrase: "a role in the regulation of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "28"

Phrase: ")"

Phrase: ","

Phrase: "its protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "evaluated in control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0220825:Evaluated [Functional Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic islets."
Processing 00000000.tx.144: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.145: 4, total protein expression was not different in nondiabetic versus diabetic islet cells. 

Phrase: "4,"

Phrase: "total protein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "was"

Phrase: "not different in nondiabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "versus"

Phrase: "diabetic islet cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: However, the percentage of activated protein was significantly lower in type 2 diabetic than control islets (Fig. 4), so that the ratio of activated to nonactivated protein was 30% lower in the former. 

Phrase: "However,"

Phrase: "the percentage of activated protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "significantly lower in type 2 diabetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "than control islets"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the ratio of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456603:Ratio [Quantitative Concept]
   790   C1547037:Ratio [Intellectual Product]

Phrase: "activated to nonactivated protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "30% lower in the former."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
Processing 00000000.tx.147: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 4. 

Phrase: "4."
Processing 00000000.tx.149: Immunoblotting experiments to evaluate total and activated protein expression of AMPK in control and type 2 diabetic (T2DM) islets. 

Phrase: "Immunoblotting experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "activated protein expression of AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1171362:protein expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetic (T2DM) islets."
Processing 00000000.tx.150: Bars represent mean and standard deviation values of five separate experiments with either control or diabetic islets. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard deviation values of five separate experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "with either control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "diabetic islets."
Processing 00000000.tx.151: *P < 0.05 vs. activated AMPK in control islets. 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. activated AMPK in control islets."
Processing 00000000.tx.152: , total AMPK; 

Phrase: ", total AMPK"

Phrase: ";"
Processing 00000000.tx.153: , activated AMPK.  

Phrase: ", activated AMPK."
Processing 00000000.tx.154: It is known that several transcription factors affect -cell function (29,30). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that several transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.155: In the current study mRNA expression of pancreatic duodenal homeobox-1 (PDX-1) and forkhead box O1 (Foxo-1) were measured, and it was found that both of these factors were expressed more in diabetic than in nondiabetic islets (Fig. 5). 

Phrase: "In the current study mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515670:mRNA Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of pancreatic duodenal homeobox-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "(PDX-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "forkhead box O1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "(Foxo-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both of these factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "expressed"

Phrase: "more in diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205172:More [Functional Concept]
   790   C0241863:DIABETIC [Finding]

Phrase: "than"

Phrase: "in nondiabetic islets"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.156: This was associated with decreased insulin expression in type 2 diabetic islet cells (Fig. 5). 

Phrase: "This"

Phrase: "was"

Phrase: "associated with decreased insulin expression"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in type 2 diabetic islet cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   881   C0449475:type cell [Intellectual Product]
   840   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   806 E C1522529:Islet Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.159: Quantitative PCR experiments to show mRNA expression of PDX-1, Foxo-1, and insulin in control (ctrl) and type 2 diabetic (T2DM) islets. 

Phrase: "Quantitative PCR experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mRNA expression of PDX-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Foxo-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "and"

Phrase: "insulin in control (ctrl)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "type 2 diabetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(T2DM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.160: Bars represent mean and standard deviation values of eight separate experiments with either control or diabetic islets. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard deviation values of eight separate experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "with either control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "diabetic islets."
Processing 00000000.tx.161: *P < 0.01 vs. control.  

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.162: The role of oxidative stress and the effects of GSH. 

Phrase: "The role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the effects of GSH."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.163: Because increased oxidative stress has been reported to be associated with the diabetic condition in several experimental and clinical settings (24,31,32), we measured the concentration of nitrotyrosine and 8-OHdG, markers of oxidative stress, directly in the islets. 

Phrase: "Because"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with the diabetic condition"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0012634:condition [Disease or Syndrome]
   760   C0241863:DIABETIC [Finding]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in several experimental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "clinical settings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C3176918:Clinical setting [Spatial Concept]
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: "(24,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the concentration of nitrotyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "8-OHdG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "markers of oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "directly in the islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.164: Both parameters were significantly higher in diabetic islets (10.1  1.1 nmol/l and 9.7  2.5 ng/ml, respectively) than in control cells (5.8  0.5 nmol/l and 1.9  0.4 ng/ml, respectively) (Fig. 6), and the concentration of nitrotyrosine as well as that of 8-OHdG were inversely and significantly correlated with insulin secretion (Fig. 7). 

Phrase: "Both parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "significantly higher in diabetic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "(10.1  1.1 nmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439282:nmol/L [Quantitative Concept]

Phrase: "and"

Phrase: "9.7  2.5 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "than"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(5.8  0.5 nmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439282:nmol/L [Quantitative Concept]

Phrase: "and"

Phrase: "1.9  0.4 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the concentration of nitrotyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "as well as"

Phrase: "that of 8-OHdG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0700307:Hydroxy [Inorganic Chemical]

Phrase: "were"

Phrase: "inversely"

Phrase: "and"

Phrase: "significantly"

Phrase: "correlated with insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1707520:Correlated [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: According to these findings, when type 2 diabetic islets were pre-exposed to the antioxidant agent GSH, a significant improvement of glucose-stimulated insulin secretion was observed, with normalization of the stimulation index (Fig. 8A). 

Phrase: "According to these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "when"

Phrase: "type 2 diabetic islets"

Phrase: "were"

Phrase: "pre-exposed to the antioxidant agent GSH,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0003402:Antioxidant [Pharmacologic Substance]
   748   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332152:Pre [Temporal Concept]
   748   C0450442:Agent [Chemical Viewed Functionally]
   748   C0740175:Pre [Qualitative Concept]
   748   C1254351:Agent [Pharmacologic Substance]
   748   C1260386:GSH [Disease or Syndrome]
   748   C1521826:Agent [Intellectual Product]
   748   C2257086:PRE [Genetic Function]

Phrase: "a significant improvement of glucose-stimulated insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986411:Improvement [Conceptual Entity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "with normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "of the stimulation index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0918012:Index [Intellectual Product]
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.166: This was associated with reduced nitrotyrosine concentration, which decreased to 5.8  1.6 nmol/l (Fig. 8B), and partial restoration of insulin mRNA expression (Fig. 8C). 

Phrase: "This"

Phrase: "was"

Phrase: "associated with reduced nitrotyrosine concentration,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0424099:Reduced concentration [Finding]
   760   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   760   C0086045:Concentration [Mental Process]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1446561:Concentration [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 5.8  1.6 nmol/l (Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "partial restoration of insulin mRNA expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449982:Restoration [Intellectual Product]

Phrase: "(Fig. 8C"

Phrase: ")."
Processing 00000000.tx.167: In nondiabetic islets, no significant change after GSH culture was observed for insulin secretion (stimulation index from 2.1  0.6 to 2.2  0.7) and nitrotyrosine level (from 5.8  0.4 to 5.7  0.5 nmol/l). 

Phrase: "In nondiabetic islets,"

Phrase: "no significant change after GSH culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0442739:No change [Finding]
   783   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]
   748   C0010451:cultural change [Human-caused Phenomenon or Process]

Phrase: "was"

Phrase: "observed for insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1441672:Observed [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(stimulation index from 2.1  0.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0918012:Index [Intellectual Product]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "to 2.2  0.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "nitrotyrosine level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "from 5.8  0.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "to 5.7  0.5 nmol/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439191:NMOLE [Quantitative Concept]
   708   C0450380:5/5 [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.168: When GSH and GSSG concentrations were measured, the values in control islets were 4.7  0.5 and 2.3  0.6 mol/mg protein, respectively, with a ratio of 2.1  0.3. 

Phrase: "When"

Phrase: "GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "and"

Phrase: "GSSG concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "the values in control islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "4.7  0.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0450367:4 5 [Quantitative Concept]
   861   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "2.3  0.6 mol/mg protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively,"

Phrase: "with a ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of 2.1  0.3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1519042:2-3 [Research Activity]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]
Processing 00000000.tx.169: In type 2 diabetic islets, lower levels of GSH (3.3  0.7 mol/mg protein) and higher levels of GSSG (4.0  0.4 mol/mg protein, P < 0.05 vs. control islets) were found, with the resulting GSH-to-GSSG ratio significantly lower than in the nondiabetic cells (0.8  0.3, P < 0.05). 

Phrase: "In type 2 diabetic islets,"

Phrase: "lower levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of GSH (3.3  0.7 mol/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "higher levels of GSSG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(4.0  0.4 mol/mg protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control islets"

Phrase: ")"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "with the resulting GSH-to-GSSG ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "significantly lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in the nondiabetic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(0.8  0.3,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.170: Pre-exposure of type 2 diabetic islets to GHS normalized these parameters (GSH: 4.2  0.6 mol/mg protein; 

Phrase: "Pre-exposure of type 2 diabetic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0362046:pre-diabetic [Disease or Syndrome]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332152:Pre [Temporal Concept]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0740175:Pre [Qualitative Concept]
   748   C2257086:PRE [Genetic Function]

Phrase: "to GHS"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "these parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "(GSH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: ":"

Phrase: "4.2  0.6 mol/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.171: GSSG: 2.1  0.4 mol/mg protein; 

Phrase: "GSSG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061516:GSSG [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ":"

Phrase: "2.1  0.4 mol/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.172: GSH-to-GSSG ratio: 2.1  0.6). 

Phrase: "GSH-to-GSSG ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "2.1  0.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.173: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 6. 

Phrase: "6."
Processing 00000000.tx.175: Nitrotyrosine and 8-OHdG concentrations in control (ctrl) and type 2 diabetic (T2DM) islets. 

Phrase: "Nitrotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "8-OHdG concentrations in control"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(ctrl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "type 2 diabetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(T2DM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.176: Bars represent mean and standard deviation values of 13 separate experiments with either control or diabetic islets. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard deviation values of 13 separate experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "with either control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "diabetic islets."
Processing 00000000.tx.177: *P < 0.01 vs. control.  

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.178: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.179: 7. 

Phrase: "7."
Processing 00000000.tx.180: Correlation of nitrotyrosine and 8-OHdG concentrations with stimulation index of type 2 diabetic islets, showing that when oxidative markers increase, glucose-stimulated insulin secretion decreases.  

Phrase: "Correlation of nitrotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "8-OHdG concentrations with stimulation index"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "of type 2 diabetic islets,"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "when"

Phrase: "oxidative markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "glucose-stimulated insulin secretion decreases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0547047:decreases [Quantitative Concept]
   771 E C0392756:Decrease [Qualitative Concept]
Processing 00000000.tx.181: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.182: 8. 

Phrase: "8."
Processing 00000000.tx.183: Stimulation index (A), nitrotyrosine concentration (B), and insulin mRNA expression (C) in diabetic islets (T2DM) either not exposed or pre-exposed for 24 h to GSH. 

Phrase: "Stimulation index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0918012:Index [Intellectual Product]
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "nitrotyrosine concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "insulin mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(C) in diabetic islets"

Phrase: "(T2DM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441730:Type 2 [Classification]
   827   C0241863:DIABETIC [Finding]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "either"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "or"

Phrase: "pre-exposed for 24 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0332152:Pre [Temporal Concept]
   760   C0332157:Exposed [Clinical Attribute]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]

Phrase: "to GSH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]
Processing 00000000.tx.184: The presence of the antioxidant determined significant improvement of glucose-stimulated insulin secretion, reduction of the oxidative stress marker, and increased expression of insulin. 

Phrase: "The presence of the antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "determined"

Phrase: "significant improvement of glucose-stimulated insulin secretion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986411:Improvement [Conceptual Entity]

Phrase: "reduction of the oxidative stress marker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0679002:reduction stress [Individual Behavior]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "increased expression of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.185: Bars represent the means  SD values of four separate experiments. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means  SD values of four separate experiments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.186: *P < 0.05 vs. type 2 diabetes.   

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.187: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  In the current study, several defects of pancreatic islets isolated from type 2 diabetic subjects were described. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In the current study,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0521116:Current [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1514811:Reference [Idea or Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "several defects of pancreatic islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "isolated from type 2 diabetic subjects"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0441730:Type 2 [Classification]
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.188: Because the percentage of -cells was only slightly (although significantly) reduced in diabetic islets as compared with control islets (10%), we are inclined to believe that the alterations we found were not merely caused by a defect of -cell mass, but that they mostly reflected primary functional and molecular alterations of the diabetic -cells. 

Phrase: "Because"

Phrase: "the percentage of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "("

Phrase: "although"

Phrase: "significantly"

Phrase: ")"

Phrase: "reduced in diabetic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0241863:DIABETIC [Finding]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "as"

Phrase: "compared with control islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(10%"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "are"

Phrase: "inclined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "the alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "not merely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "caused by a defect of -cell mass,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0007634:Cell [Cell]
   748   C0577559:Mass [Finding]
   748   C1269647:Cell [Cell]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1457869:Defect [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1861101:DEFECT [Disease or Syndrome]
   748   C1948049:Cell [Spatial Concept]
   748   C3152252:Mass [Quantitative Concept]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "but"

Phrase: "that"

Phrase: "they mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "primary functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "molecular alterations of the diabetic -cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.189: We confirm that type 2 diabetic islets release less insulin than control islets in response to glucose (12,14), and we show, for the first time, that this is accompanied by altered expression of glucotransporters (in particular GLUT2) and of glucokinase. 

Phrase: "We"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that type 2 diabetic islets"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "less insulin than control islets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(12,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "for the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "accompanied by altered expression of glucotransporters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0392747:Altered [Functional Concept]

Phrase: "("

Phrase: "in particular GLUT2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420172:GLUT2 [Gene or Genome]

Phrase: ")"

Phrase: "and of glucokinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415014:GLUCOKINASE [Gene or Genome]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.190: GLUT2 has high transport capacity and Km for glucose, so that the rate of transport of this exose by GLUT2 is largely dependent on the ambient glucose concentration (33). 

Phrase: "GLUT2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "has"

Phrase: "high transport capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "Km for glucose,"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the rate of transport of this exose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "by GLUT2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "is"

Phrase: "largely dependent on the ambient glucose concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.191: On the other hand, glucokinase (hexoki-nase IV) exhibits low affinity for glucose, and it is considered the rate-limiting step for glucose metabolism in the -cell (34,35). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "(hexoki-nase"

Phrase: "IV)"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "low affinity for glucose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0860801:Glucose low [Finding]
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the rate-limiting step for glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "in the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.192: Alterations of both proteins (and in particular of glucokinase activity) have been associated with diabetes (36). 

Phrase: "Alterations of both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "("

Phrase: "and in particular of glucokinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1150444:glucokinase activity [Molecular Function]
   753   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1415014:GLUCOKINASE [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.193: In our study, we did not perform experiments to evaluate glucose transport and phosphorylation in the isolated islets. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "phosphorylation in the isolated islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.194: Therefore, it is not possible to directly infer the relationship between kinetic data of glucose transport/phosphorylation and subsequent functional effects. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "not possible to directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0332149:Possible [Qualitative Concept]
   812   C1518422:Not [Functional Concept]
   812   C1705910:Possible [Qualitative Concept]
   812   C1947931:Directly [Qualitative Concept]
   812   C2362652:Possible [Qualitative Concept]

Phrase: "infer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "the relationship between kinetic data of glucose transport/phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "subsequent functional effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.195: However, it is of some interest that in type 2 diabetic islets the 4050% decrease of GLUT2 and glucokinase mRNA expression correlated well with the observed 50% reduction of glucose oxidation. 

Phrase: "However,"

Phrase: "it"

Phrase: "is of some"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that in type 2 diabetic islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "the 4050% decrease of GLUT2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "glucokinase mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "well with the observed 50% reduction of glucose oxidation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C0030012:Oxidation-Reduction [Molecular Function]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0030011:Oxidation [Molecular Function]
   742   C0205170:Well [Qualitative Concept]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C1441672:Observed [Functional Concept]
   742   C3146287:Well [Manufactured Object]
Processing 00000000.tx.196: We found that the defect of insulin release upon nonglucose stimuli was less markedly affected, which is in agreement with previous studies showing that amino acid-induced insulin secretion is better maintained in type 2 diabetic islets (12). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the defect of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "upon nonglucose stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "was"

Phrase: "less markedly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439092:less [Intellectual Product]
   861   C0522501:Markedly [Qualitative Concept]
   861   C0547044:Less [Qualitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "which"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that amino acid-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1160577:acid secretion [Cell Function]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "maintained in type 2 diabetic islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0024501:Maintain [Activity]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.197: In addition, we observed that both arginine and glibenclamide induced an early insulin secretion phase from the diabetic islets. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "both arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an early insulin secretion phase from the diabetic islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.198: Both arginine (by increasing intracellular positive charge) and sulfonylureas (by inhibiting K+ loss from -cell) cause depolarization of -cell membrane (37). 

Phrase: "Both arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "by increasing intracellular positive charge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2825490:Positive Charge [Qualitative Concept]
   812   C0007961:Charge [Quantitative Concept]
   812   C1706211:Charge [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "sulfonylureas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038766:SULFONYLUREAS [Organic Chemical,Pharmacologic Substance]
   966 E C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "("

Phrase: "by inhibiting K+ loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "from -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "depolarization of -cell membrane"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0007603:Cell Membrane [Cell Component]
   861   C3161472:Cell Membrane [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1706182:Membrane [Manufactured Object]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.199: This event is followed by Ca2+ entry, increased cytosolic Ca2+ concentration, and translocation and exocytosis of insulin granules (37). 

Phrase: "This event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "is"

Phrase: "followed by Ca2+ entry,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1705654:Entry [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cytosolic Ca2+ concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "exocytosis of insulin granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015283:Exocytosis [Cell Function]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.200: Altogether, these findings underline the importance of searching for selective -cell defects in the pathways leading from glucose transport to exocytosis of the insulin granules. 

Phrase: "Altogether,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "underline"

Phrase: "the importance of searching"

Phrase: "for selective -cell defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "leading from glucose transport"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0332152:Leading [Temporal Concept]
   770   C1317949:Transport [Manufactured Object]
   770   C1522538:Leading [Functional Concept]
   770   C3495449:transport [Medical Device]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "of the insulin granules."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   777 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.201: Based on the available evidence (12, the current study) we are inclined to believe that the defects of glucose-stimulated insulin release in type 2 diabetic -cells lie between glucose transport and depolarization of the cellular membrane. 

Phrase: "Based on the available evidence"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0332120:Evidence [Functional Concept]
   760   C0470187:Available [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(12,"

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "we"

Phrase: "are"

Phrase: "inclined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "the defects of glucose-stimulated insulin release"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in type 2 diabetic -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "lie between glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "depolarization of the cellular membrane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1816453:membrane depolarization [Cell Function]
Processing 00000000.tx.202: In this regard, alteration of mitochondrial function might play a crucial role, as recently suggested (38). 

Phrase: "In this regard,"

Phrase: "alteration of mitochondrial function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   770   C1515926:Alteration [Idea or Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "as"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.203: A novel finding of the current report is the reduced activation of AMPK that was observed in type 2 diabetic islets compared with control islets. 

Phrase: "A novel finding of the current report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "the reduced activation of AMPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "that"

Phrase: "was"

Phrase: "observed in type 2 diabetic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "compared with control islets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.204: AMPK is a multisubstrate kinase regulated by AMP, and it controls a number of metabolic enzymes with the aim of reducing cellular ATP consumption during conditions of metabolic stress (28). 

Phrase: "AMPK"

Phrase: "is"

Phrase: "a multisubstrate kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulated by AMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "it"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "a number of metabolic enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "with the aim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]

Phrase: "of reducing cellular ATP consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0009830:Consumption [Activity]
   812   C1947907:Consumption [Physiologic Function]

Phrase: "during conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of metabolic stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2350024:Metabolic Stress [Organism Attribute]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.205: Activation of AMPK is considered to have beneficial effects on diabetes because it improves insulin action in the muscle and liver (28). 

Phrase: "Activation of AMPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "beneficial effects on diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "improves"

Phrase: "insulin action in the muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0920875:Muscle action [Organ or Tissue Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.206: This kinase has been recently implicated in the control of insulin secretion. 

Phrase: "This kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "implicated in the control of insulin secretion."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0243148:control [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550141:Control [Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.207: Some researchers have reported that increased activity of AMPK leads to inhibition of glucose-stimulated insulin release in MIN6 cells and rodent islets, whereas in other studies activation of AMPK potentiated glucose-induced insulin secretion from isolated rat islets or perfused pancreata (22,39). 

Phrase: "Some researchers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Researchers [Professional or Occupational Group]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that increased activity of AMPK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0474395:increased activity [Finding]
   797   C3546468:AMPK activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "leads to inhibition of glucose-stimulated insulin release"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0181586:leads [Medical Device]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1948023:Stimulated [Natural Phenomenon or Process]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   744   C3463820:Inhibition [Activity]

Phrase: "in MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rodent islets,"

Phrase: "whereas in other studies activation of AMPK"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0947630:studies [Laboratory Procedure]
   748   C1879547:Activation [Activity]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "potentiated"

Phrase: "glucose-induced insulin secretion from isolated rat islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1256369:insulin secretion [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "or"

Phrase: "perfused pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(22,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.208: Because in nondiabetic human islets activation of AMPK by AICAR (5-imidazolecarboxamide riboside) induces a potentiation of insulin release (R. Lupi, unpublished observations), we are inclined to believe that the reduced amount of activated AMPK that we observed in type 2 diabetic islets may contribute to the defect of insulin secretion. 

Phrase: "Because in nondiabetic human islets activation of AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086418:Human [Human]
   744   C1879547:Activation [Activity]

Phrase: "by AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051028:AICAR [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C3273396:AICAR [Gene or Genome]

Phrase: "(5-imidazolecarboxamide riboside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597413:riboside [Carbohydrate]

Phrase: ")"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a potentiation of insulin release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "(R. Lupi,"

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "are"

Phrase: "inclined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "the reduced amount of activated AMPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "observed in type 2 diabetic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "contribute to the defect of insulin secretion."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1457869:Defect [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1861101:DEFECT [Disease or Syndrome]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.209: For the first time, we report that some transcription factors regulating -cell differentiation and function are altered in type 2 diabetic islets. 

Phrase: "For the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "some transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "regulating -"

Phrase: "cell differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "are"

Phrase: "altered in type 2 diabetic islets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   767   C1425576:ISLET 2 [Gene or Genome]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C0392747:Altered [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.210: PDX-1 has a crucial role in early organogenesis and is also a key regulator of differentiated -cells (29,30,40). 

Phrase: "PDX-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "a crucial role in early organogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "a key regulator of differentiated -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "(29,"

Phrase: "30,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.211: This factor supports insulin gene transcription and activates a large number of genes involved in normal -cell function and survival. 

Phrase: "This factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a large number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "involved in normal -cell function"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   806   C0007613:Cell Function [Cell Function]
   806   C0007634:Normal cell [Cell]
           Cell
   806   C1268443:Normal cell [Cell]
   760   C0031843:function [Physiologic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705273:Function [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.212: We found that in type 2 diabetic isolated islets, mRNA expression of PDX-1 was increased, despite the augmented expression of Foxo-1, which is considered an inhibitor of PDX-1 gene expression (29,30). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in type 2 diabetic isolated islets,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0441730:Type 2 [Classification]
   757   C1425576:ISLET 2 [Gene or Genome]
   748   C0205409:Isolated [Functional Concept]
   748   C0241863:DIABETIC [Finding]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1548221:Isolated [Idea or Concept]

Phrase: "mRNA expression of PDX-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "despite the augmented expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Foxo-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "which"

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "an inhibitor of PDX-1 gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C0079925:Gene Expression Inhibitor [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C1418824:INHIBITOR 1 [Gene or Genome]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.213: The increased PDX-1 mRNA expression may be interpreted as an attempt to compensate for the reduced -cell function of type 2 diabetic islets. 

Phrase: "The increased PDX-1 mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C1515670:mRNA Expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "interpreted as an attempt to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1285553:interpreted [Functional Concept]
   760   C1516084:Attempt [Event]

Phrase: "compensate for the reduced -cell function of type 2 diabetic islets."
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   770   C0449475:Type of cell [Intellectual Product]
           cell type
   756   C0007613:Cell Function [Cell Function]
   756   C0441730:Type 2 [Classification]
   754   C0007634:Cell Type [Cell]
           Cell
   754   C0022131:cell islets [Body Part, Organ, or Organ Component]
   738   C0031843:function [Physiologic Function]
   738   C0205432:compensate [Qualitative Concept]
   738   C0241863:DIABETIC [Finding]
   738   C0332307:Type [Qualitative Concept]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1269647:Cell [Cell]
   738   C1547052:*Type [Quantitative Concept]
   738   C1704653:Cell [Medical Device]
   738   C1705273:Function [Intellectual Product]
   738   C1948049:Cell [Spatial Concept]
   737   C1425576:ISLET 2 [Gene or Genome]
   737 E C1522529:Islet Cell [Cell]
Processing 00000000.tx.214: However, the effects of this effort remain elusive because gene transcription of key proteins of -cell function (such as GLUTs and insulin, as observed in our experiments) remained lower than that observed in control islets. 

Phrase: "However,"

Phrase: "the effects of this effort"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "remain"

Phrase: "elusive"

Phrase: "because"

Phrase: "gene transcription of key proteins of -cell function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "("

Phrase: "such as GLUTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1335837:GLUT [Gene or Genome]
   966   C1705603:GLUT [Gene or Genome]

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "observed in our experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1441672:Observed [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: ")"

Phrase: "remained"

Phrase: "lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "observed in control islets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.215: Our findings on the increased PDX-1 mRNA expression in type 2 diabetic islets are at odds with data showing that PDX-1 expression is reduced in animal models of diabetes (31). 

Phrase: "Our findings on the increased PDX-1 mRNA expression"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   738   C2607943:findings [Functional Concept]
   738   C2926606:Findings [Clinical Attribute]
   738   C3539655:Findings [Intellectual Product]
   737   C0940338:Duodenal finding [Finding]
   737   C0940730:Pancreatic finding [Finding]
   704 E C0037088:Finding [Sign or Symptom]
   704 E C0243095:Finding [Finding]
   704 E C2825141:Finding [Finding]

Phrase: "in type 2 diabetic islets"

Phrase: "are at odds with data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1511726:Data [Idea or Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PDX-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "reduced in animal models of diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0392756:Reduced [Qualitative Concept]
   753   C3161035:Models [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: In addition, it has been reported that chronic oxidative stress may decrease PDX-1 transcription in cell line experiments (41). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that chronic oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "PDX-1 transcription in cell line experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   791   C0681814:Experiments [Research Activity]
   758 E C1706386:Experiment [Conceptual Entity]
   708 E C1517586:Experimental [Qualitative Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.217: This controversial issue will therefore require further studies to better understand the complex network of signals and regulatory factors driving PDX-1 regulation and function in type 2 diabetes. 

Phrase: "This controversial issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]

Phrase: "will"

Phrase: "therefore"

Phrase: "require"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the complex network of signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1513822:Network [Professional or Occupational Group]
   760   C1705739:Network [Manufactured Object]
   760   C1882071:Network [Conceptual Entity]

Phrase: "and"

Phrase: "regulatory factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "PDX-1 regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "function in type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.218: Many studies suggest that type 2 diabetic patients are subjected to chronic oxidative stress (24,31,32). 

Phrase: "Many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "subjected to chronic oxidative stress"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0205191:chronic [Temporal Concept]
   760   C0311404:Oxidative [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "(24,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.219: Hyperglycemia and increased free fatty acid concentration can contribute to the formation of reactive oxygen species, which in turn damage cell proteins and DNA. 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "increased free fatty acid concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]
   717   C0015688:free fatty acid [Lipid]
   717   C2698488:Free Fatty Acid [Laboratory Procedure]

Phrase: "can"

Phrase: "contribute to the formation of reactive oxygen species,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1705920:Species [Conceptual Entity]
   744   C1880177:Contribute [Activity]

Phrase: "which in turn damage cell proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0007634:Cell [Cell]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.220: In islet -cells, oxidative stress is even more dangerous than in other tissues because of the low intrinsic antioxidant capacity of the -cell (41,42). 

Phrase: "In islet -cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "even more dangerous than"

Phrase: "in other tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "because of the low intrinsic antioxidant capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003402:Antioxidant [Pharmacologic Substance]
   812   C1516240:Capacity [Quantitative Concept]

Phrase: "of the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.221: In our experiments, we found that levels of nitrotyrosine and 8-OHdG, which are markers of oxidative stress, are higher in type 2 diabetes than in control islets, and for the first time we demonstrate a correlation between the concentration of these compounds and the degree of insulin secretion impairment. 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that levels of nitrotyrosine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "8-OHdG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "are"

Phrase: "markers of oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "higher in type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in control islets,"

Phrase: "and for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "a correlation between the concentration of these compounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the degree of insulin secretion impairment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.222: Notably, the addition of GSH in the incubation medium determined reduction of oxidative stress (as suggested by the diminished levels of nitrotyrosine), improved glucose-stimulated insulin secretion, and increased insulin mRNA expression. 

Phrase: "Notably,"

Phrase: "the addition of GSH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "in the incubation medium determined reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0301630:Reduction [Natural Phenomenon or Process]
   812   C0392756:Reduction [Qualitative Concept]
   812   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "suggested by the diminished levels of nitrotyrosine"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   748   C0205216:Diminished [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714   C1705535:Suggest [Idea or Concept]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "improved glucose-stimulated insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "increased insulin mRNA expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515670:mRNA Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.223: These novel findings support the observation by Paolisso et al. 

Phrase: "These novel findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the observation by Paolisso et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.224: (43) that in patients with impaired glucose tolerance, GSH infusion ameliorated insulin secretion, and they add value to the numerous experimental data demonstrating that potentiating -cell antioxidant defenses is a means to protect the islet cells from oxidative stress (24,31,32,41,42). 

Phrase: "(43"

Phrase: ")"

Phrase: "that in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "with impaired glucose tolerance,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "GSH infusion ameliorated insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "they"

Phrase: "add"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883712:Add [Functional Concept]

Phrase: "value to the numerous experimental data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1704610:Data Value [Intellectual Product]
   753   C1522609:Value [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that potentiating -cell antioxidant defenses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003402:Antioxidant [Pharmacologic Substance]
   812   C1880266:Defense [Conceptual Entity]

Phrase: "is"

Phrase: "a means to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "protect"

Phrase: "the islet cells from oxidative stress"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   767   C0007634:THE CELL [Cell]
           Cells
   756 E C1522529:Islet Cell [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(24,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.225: Most importantly, our findings demonstrate that the defects of glucose-stimulated insulin release of type 2 diabetic islets are reversible, at least in part. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the defects of glucose-stimulated insulin release of type 2 diabetic islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   736   C0243067:defects [Functional Concept]
   703 E C1457869:Defect [Functional Concept]
   703 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "are"

Phrase: "reversible,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.226: In the current study we did not perform experiments to evaluate the in vivo function of type 2 diabetic islets. 

Phrase: "In the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the in vivo function of type 2 diabetic islets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]
Processing 00000000.tx.227: A previous report by Deng et al. 

Phrase: "A previous report by Deng et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]
Processing 00000000.tx.228: (14) has clearly shown that, as compared with control islets, islets prepared from diabetic subjects were less effective in curing diabetic mice. 

Phrase: "(14"

Phrase: ")"

Phrase: "has"

Phrase: "clearly"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "as"

Phrase: "compared with control islets,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "islets"

Phrase: "prepared from diabetic subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0241863:DIABETIC [Finding]
   737   C0681850:Subject [Group]
   737   C1521827:Prepare [Functional Concept]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "less effective in curing diabetic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.229: Further work is needed to determine whether the reversibility of the defective in vitro function, as reported in our study, is accompanied by improved in vivo performance. 

Phrase: "Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the reversibility of the defective in vitro function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449261:Reversibility [Temporal Concept]

Phrase: "as"

Phrase: "reported in our study,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "is"

Phrase: "accompanied by improved in vivo performance."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0184511:Improved [Qualitative Concept]
   753   C0332272:Improved [Qualitative Concept]
   753   C0597198:Performance [Individual Behavior]
   753   C1561611:Improved [Intellectual Product]
   753   C1882330:Performance [Activity]
Processing 00000000.tx.230: Finally, it should be noted that in the current experiments, despite 34 days of culture in euglycemic medium, insulin secretion function from diabetic islets did not improve in the absence of GSH. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that in the current experiments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0521116:Current [Temporal Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1705970:Current [Natural Phenomenon or Process]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "despite 34 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "in euglycemic medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "insulin secretion function from diabetic islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   748   C0544458:Secretion, functional [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "improve in the absence of GSH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1260386:GSH [Disease or Syndrome]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.231: This indicates that recovery from the possible deleterious effects of glucotoxicity may require longer times, and that the changes we observed were indeed directly caused by the pharmacological addition. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that recovery from the possible deleterious effects of glucotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0237820:Recovery [Activity]
   742   C1555688:recovery [Idea or Concept]
   742   C2004454:Recovery [Organism Function]

Phrase: "may"

Phrase: "require"

Phrase: "longer times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "indeed directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947931:Directly [Qualitative Concept]

Phrase: "caused by the pharmacological addition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   760   C0205464:pharmacological [Functional Concept]
   760   C1883712:Addition [Functional Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.232: It should be noted that islets prepared from the pancreata of type 1 diabetic patients show recovered function after a few days of in vitro culture (44), suggesting that the islets native microenvironment plays a more important role in type 1 diabetes than in type 2 diabetes in negatively affecting the -cell. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that islets"

Phrase: "prepared from the pancreata of type 1 diabetic patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0441729:Type 1 [Classification]
   745   C1550335:Patient type [Classification]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   708   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   708   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   708   C1521827:Prepare [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "recovered function after a few days of in vitro culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the islets native microenvironment"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a more important role in type 1 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "than"

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in negatively"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.233: In conclusion, our results show for the first time that the functional defects of -cells in type 2 diabetes are associated with multiple functional and molecular alterations and increased oxidative stress, which may be targets for therapeutic approaches. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1547282:Show [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that"

Phrase: "the functional defects of -cells in type 2 diabetes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   773   C0449475:Type of cell [Intellectual Product]
           cells type
   745 E C0007634:Cell Type [Cell]
           THE CELL
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "associated with multiple functional"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205245:Functional [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "molecular alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "increased oxidative stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0231298:Increased stress [Functional Concept]
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "targets for therapeutic approaches."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.234: In fact, reduction of islet cell oxidative stress was accompanied by improved secretory capability, which suggests that the decline in -cell function commonly observed in type 2 diabetic patients may not be relentless.  

Phrase: "In fact,"

Phrase: "reduction of islet cell oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0679002:reduction stress [Individual Behavior]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "accompanied by improved secretory capability,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0184511:Improved [Qualitative Concept]
   760   C0332272:Improved [Qualitative Concept]
   760   C1327616:Secretory [Cell Function]
   760   C1561611:Improved [Intellectual Product]
   760   C2698977:Capability [Qualitative Concept]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decline"

Phrase: "in -cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "commonly"

Phrase: "observed in type 2 diabetic patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0441730:Type 2 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "relentless."
Processing 00000000.tx.235: ACKNOWLEDGMENTS  This work was supported by the Italian Ministry of Health and the Italian Ministry of University and Scientific Research (COFIN 2001-2002 and 2002-2003). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Italian Ministry of Health"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0018684:Health [Idea or Concept]
   748   C0022275:ITALIAN [Language]
   748   C0337810:Italian [Population Group]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "the Italian Ministry of University"

Phrase: "and"

Phrase: "Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "(COFIN 2001-2002"

Phrase: "and"

Phrase: "2002-2003"

Phrase: ")."
Processing 00000000.tx.236: Address correspondence and reprint requests to Piero Marchetti MD, Department of Endocrinology and Metabolism, Metabolic Unit, Ospedale Cisanello, Via Paradisa 2, 56124 Pisa, Italy. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Piero Marchetti MD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0686900:request [Functional Concept]
   760   C1272683:Request [Functional Concept]
   760   C1522634:Request [Intellectual Product]

Phrase: "Department of Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587463:Endocrinology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Metabolic Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Ospedale Cisanello,"

Phrase: "Via Paradisa 2,"

Phrase: "56124 Pisa,"

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]
Processing 00000000.tx.237: E-mail marchant{at}immr.med.unipi.it Received for publication August 19, 2004 and accepted in revised form November 30, 2004 AMPK, AMP-activated protein kinase; 

Phrase: "E-mail marchant{at}immr.med.unipi."

Phrase: "it"

Phrase: "Received for publication August 19,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form November 30,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2004 AMPK,"

Phrase: "AMP-activated protein kinase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   902   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.238: Foxo-1, forkhead box O1; 

Phrase: "Foxo-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "forkhead box O1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333572:forkhead box O1 [Gene or Genome]
   901   C3273493:Fork Head Box [Amino Acid Sequence]
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: ";"
Processing 00000000.tx.239: GSH, glutathione; 

Phrase: "GSH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1260386:GSH [Disease or Syndrome]

Phrase: "glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.240: GSSG, GSH disulfide; 

Phrase: "GSSG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061516:GSSG [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "GSH disulfide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012771:disulfide [Chemical Viewed Structurally]
   861   C0017817:GSH [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1260386:GSH [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.241: KRB, Krebs-Ringer bicarbonate solution; 

Phrase: "KRB,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   875   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "Krebs-Ringer bicarbonate solution"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0064411:Krebs-Ringer solution [Organic Chemical,Pharmacologic Substance]
           Krebs solution
   875   C0073386:Ringer's solution [Inorganic Chemical,Pharmacologic Substance]
   812   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   812   C0973231:Bicarbonate [Inorganic Chemical]
   812   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   812   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.242: 8-OHdG, 8-hydroxy-2'-deoxyguanosine; 

Phrase: "8-OHdG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-hydroxy-2'-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.243: PDX-1, pancreatic duodenal homeobox-1  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Zimmet P, Alberti KGMM, Shaw J: Global and societal implications of the diabetes epidemic. 

Phrase: "PDX-1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "pancreatic duodenal homeobox-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Zimmet P,"

Phrase: "Alberti KGMM,"

Phrase: "Shaw J"

Phrase: ":"

Phrase: "Global"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205246:Global [Spatial Concept]
  1000   C2348867:Global [Qualitative Concept]
   928 E C0015392:globe [Body Part, Organ, or Organ Component]
   928 E C1280202:Globe [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "societal implications of the diabetes"

Phrase: "epidemic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014499:Epidemic [Phenomenon or Process]
Processing 00000000.tx.244: Nature414 :782 787,2001[Medline] Amos AF, McCarthy D, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. 

Phrase: "Nature414"

Phrase: ":"

Phrase: "782 787,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Amos AF,"

Phrase: "McCarthy D,"

Phrase: "Zimmet P"

Phrase: ":"

Phrase: "The rising global burden of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "its complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: ":"

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]

Phrase: "and"

Phrase: "projections to the year 2010."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016538:projections [Intellectual Product]
   760   C0033363:projections [Mental Process]
   760   C0348018:projections [Spatial Concept]
Processing 00000000.tx.245: Diabet Med14 :S1 S85,1997[Medline] American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. 

Phrase: "Diabet Med14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1332781:MED14 [Gene or Genome]

Phrase: ":"

Phrase: "S1 S85,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: ":"

Phrase: "Economic consequences of diabetes mellitus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in the U.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]

Phrase: "in 1997."
Processing 00000000.tx.246: Diabetes Care21 :296 309,1998[Abstract] Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 

Phrase: "Diabetes Care21"

Phrase: ":"

Phrase: "296 309,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Alberti KG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "Zimmet PZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1418952:PZ [Gene or Genome]

Phrase: ":"

Phrase: "Definition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550452:definition [Idea or Concept]
  1000   C1704788:Definition [Conceptual Entity]
  1000   C3539107:Definition [Intellectual Product]

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "classification of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]

Phrase: "and"

Phrase: "its complications."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.247: Part 1. 

Phrase: "Part 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.248: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. 

Phrase: "Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "classification of diabetes mellitus provisional report of a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0008902:Classification [Classification]
   744   C0008903:classification [Functional Concept]
   744   C0678229:classification [Occupational Activity]

Phrase: "WHO consultation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009818:Consultation [Health Care Activity]
Processing 00000000.tx.249: Diabet Med15 :539 553,1998[Medline] McCarthy MI, Froguel P: Genetic approaches to the molecular understanding of type 2 diabetes. 

Phrase: "Diabet Med15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0378666:MED15 [Organic Chemical,Pharmacologic Substance]
   861   C1422509:MED15 [Gene or Genome]

Phrase: ":"

Phrase: "539 553,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCarthy MI,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Genetic approaches to the molecular understanding of type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0449445:Approaches [Spatial Concept]
   739   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.250: Am J Physiol Endocrinol Metab283 :E217 E225,2002[Abstract/Free FullText] Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab283"

Phrase: ":"

Phrase: "E217 E225,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Atkinson MA,"

Phrase: "Maclaren NK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: ":"

Phrase: "The pathogenesis of insulin-dependent diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.251: N Engl J Med U S A331 :1428 1436,1994 Polonsky KS, Sturis J, Bell JI: Non-insulin dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. 

Phrase: "N Engl J Med U S A331"

Phrase: ":"

Phrase: "1428 1436,"

Phrase: "1994 Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541894:ks [Quantitative Concept]

Phrase: "Sturis J,"

Phrase: "Bell JI"

Phrase: ":"

Phrase: "Non-insulin dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "a genetically programmed failure of the beta cell to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0231174:Failure [Functional Concept]
   742   C0680095:failure [Individual Behavior]

Phrase: "compensate for insulin resistance."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205432:compensate [Qualitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.252: N Engl J Med334 :777 783,1996[Free FullText] Kahn S: The importance of beta-cell failure in the development and progression of type 2 diabetes mellitus. 

Phrase: "N Engl J Med334"

Phrase: ":"

Phrase: "777 783,"

Phrase: "1996"

Phrase: "[Free FullText"

Phrase: "] Kahn S"

Phrase: ":"

Phrase: "The importance of beta-cell failure"

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "progression of type 2 diabetes mellitus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
   716   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
   716   C2984301:Type II diabetes mellitus [Functional Concept]
Processing 00000000.tx.253: J Clin Endocrinol Metab86 :4047 4058,2001[Free FullText] Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E: Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "4047 4058,"

Phrase: "2001"

Phrase: "[Free FullText"

Phrase: "] Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Given BD,"

Phrase: "Hirsch LJ,"

Phrase: "Tillil H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shapiro ET, Beebe C,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Galloway JA,"

Phrase: "Van Cauter E"

Phrase: ":"

Phrase: "Abnormal patterns of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Patterns [Spatial Concept]

Phrase: "in non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.254: N Engl J Med318 :1231 1239,1998 Schmitz O, Brock B, Hollingdal M, Juhl CB, Porksen N: High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology. 

Phrase: "N Engl J Med318"

Phrase: ":"

Phrase: "1231 1239,"

Phrase: "1998 Schmitz O,"

Phrase: "Brock B,"

Phrase: "Hollingdal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Juhl CB,"

Phrase: "Porksen N"

Phrase: ":"

Phrase: "High-frequency insulin pulsatility"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0577317:Pulsatility [Qualitative Concept]
   741 E C0439606:Pulsatile [Temporal Concept]
   708   C0020459:high insulin [Disease or Syndrome]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "from physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "and"

Phrase: "pathophysiology to clinical pharmacology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031847:pathophysiology [Functional Concept]
   770   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.255: Diabetes Metab28 :4S 144S20,2002 Weyer C, Bogardus C, Mott D, Prateley R: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. 

Phrase: "Diabetes Metab28"

Phrase: ":"

Phrase: "4S 144S20,"

Phrase: "2002 Weyer C,"

Phrase: "Bogardus C,"

Phrase: "Mott D,"

Phrase: "Prateley R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "The natural history of insulin secretory dysfunction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0175860:Natural History [Occupation or Discipline]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0205296:Natural [Functional Concept]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]

Phrase: "and"

Phrase: "insulin resistance in the pathogenesis of type 2 diabetes mellitus."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   799   C0342335:Insulin resistance in diabetes [Disease or Syndrome]
           diabetes insulin resistance
   773   C0743125:Insulin resistant diabetes mellitus [Disease or Syndrome]
   760   C0021655:Insulin Resistance [Pathologic Function]
   760   C2700570:INSULIN RESISTANCE [Gene or Genome]
   757   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753 E C0854110:Insulin resistant diabetes [Disease or Syndrome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0237834:Resistance [Mental Process]
   739   C1514892:Resistance [Physiologic Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.256: J Clin Invest104 :787 794,1999[Abstract/Free FullText] Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ: Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. 

Phrase: "J Clin Invest104"

Phrase: ":"

Phrase: "787 794,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fernandez-Alvarez J,"

Phrase: "Conget I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rasschaert J,"

Phrase: "Sener A,"

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Malaisse WJ"

Phrase: ":"

Phrase: "Enzymatic, metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "secretory patterns in human islets of type 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Patterns [Spatial Concept]

Phrase: "(non-insulin-dependent) diabetic patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1829939:{Non-patient} [Clinical Attribute]
   853   C0581116:dependent patients [Functional Concept]
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.257: Diabetologia37 :177 181,1994[Medline] Lin JM, Fabregat ME, Gomis R, Bergsten P: Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. 

Phrase: "Diabetologia37"

Phrase: ":"

Phrase: "177 181,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Fabregat"

Phrase: "ME,"

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bergsten P"

Phrase: ":"

Phrase: "Pulsatile insulin release from islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "isolated from three subjects"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0205409:Isolated [Functional Concept]
   770   C0205449:Three [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.258: Diabetes51 :988 993,2002[Abstract/Free FullText] Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B, Barker CF, Naji A, Matschinsky FM, Markmann JF: Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "988 993,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Deng S,"

Phrase: "Vatamaniuk M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang X,"

Phrase: "Doliba N,"

Phrase: "Lian MM,"

Phrase: "Frank A,"

Phrase: "Velidedeoglu E,"

Phrase: "Desai NM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Koeberlein B,"

Phrase: "Wolf B,"

Phrase: "Barker CF,"

Phrase: "Naji A,"

Phrase: "Matschinsky FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Markmann JF"

Phrase: ":"

Phrase: "Structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional abnormalities in the islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "isolated from type 2 diabetic subjects."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0441730:Type 2 [Classification]
   753   C0205409:Isolated [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.259: Diabetes53 :624 632,2004[Abstract/Free FullText] Marchetti P, Dotta F, Ling Z, Lupi R, Del Guerra S, Santangelo C, Realacci M, Marselli L, Di Mario U, Navalesi R: Function of pancreatic islets isolated from a type 1 diabetic patient. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "624 632,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marchetti P,"

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ling Z,"

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Del Guerra S,"

Phrase: "Santangelo C,"

Phrase: "Realacci M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Marselli L,"

Phrase: "Di Mario U,"

Phrase: "Navalesi R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Function of pancreatic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   865   C0597166:pancreatic islet function [Organ or Tissue Function]
   819   C0232786:Pancreatic function [Organ or Tissue Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "isolated from a type 1 diabetic patient."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0441729:Type 1 [Classification]
   774   C1550335:Patient type [Classification]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0205409:Isolated [Functional Concept]
   748   C0241863:DIABETIC [Finding]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.260: Diabetes Care23 :701 703,2000[Free FullText] Marselli L, Dotta F, Piro S, Santangelo C, Masini M, Lupi R, Realacci M, del Guerra S, Mosca F, Boggi U, Purrello F, Navalesi R, Marchetti P: Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. 

Phrase: "Diabetes Care23"

Phrase: ":"

Phrase: "701 703,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Marselli L,"

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Piro S,"

Phrase: "Santangelo C,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Realacci M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "del Guerra S,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Navalesi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Th2 cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "a partial, direct protective effect on the function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "survival of isolated human islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "exposed to combined proinflammatory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0205195:Combined [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "Th1 cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.261: J Clin Endocrinol Metab86 :4974 4978,2001[Abstract/Free FullText] Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patane G, Boggi U, Mosca F, Piro S, Del Prato S, Marchetti P: Lipotoxicity in human pancreatic islets and the protective effect of metformin. 

Phrase: "J Clin Endocrinol Metab86"

Phrase: ":"

Phrase: "4974 4978,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Del Guerra S,"

Phrase: "Fierabracci V,"

Phrase: "Marselli L,"

Phrase: "Novelli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Piro S,"

Phrase: "Del Prato S,"

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Lipotoxicity in human pancreatic islets"

Phrase: "and"

Phrase: "the protective effect of metformin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.262: Diabetes51 :S134 S137,2002[Abstract/Free FullText] Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "S134 S137,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marselli L,"

Phrase: "Del Guerra S,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Santangelo C,"

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Boggi U,"

Phrase: "Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bergamini E,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Mario U,"

Phrase: "Del Prato S,"

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Prolonged exposure to free fatty acids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0439590:Prolonged [Temporal Concept]

Phrase: "has"

Phrase: "cytostatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010858:cytostatic [Pharmacologic Substance]

Phrase: "and"

Phrase: "pro-apoptotic effects on human pancreatic islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that beta-cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007587:Cell Death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
   734   C0030281:Beta cell [Cell]

Phrase: "is"

Phrase: "caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "partially dependent on ceramide pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.263: Diabetes51 :1437 1442,2002[Abstract/Free FullText] Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patane G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S: Insulin secretory function is impaired in isolated human islets carrying the Gly(972)>Arg IRS-1 polymorphism. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "1437 1442,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marchetti P,"

Phrase: "Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Marselli L,"

Phrase: "Masini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Boggi U,"

Phrase: "Del Guerra S,"

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Piro S,"

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bergamini E,"

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Del Prato S"

Phrase: ":"

Phrase: "Insulin secretory function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0544458:Secretory function [Functional Concept]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "impaired in isolated human islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C0205409:Isolated [Functional Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1548221:Isolated [Idea or Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Gly(972"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ">Arg IRS-1 polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.264: Diabetes51 :1419 1424,2002[Abstract/Free FullText] Patan G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM: Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor- inhibition. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "1419 1424,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Patan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Anello M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Piro S,"

Phrase: "Vigneri R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Purrello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rabuazzo"

Phrase: "AM"

Phrase: ":"

Phrase: "Role of ATP production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "uncoupling protein-2 in the insulin secretory defect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0536847:uncoupling protein-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C1421314:UNCOUPLING PROTEIN 2 [Gene or Genome]
   767   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced by chronic exposure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205191:chronic [Temporal Concept]
   770   C0205263:Induced [Functional Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "effects of peroxisome proliferator-activated receptor- inhibition."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.265: Diabetes51 :2749 2756,2002[Abstract/Free FullText] Lupi R, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, Del Prato S: Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "2749 2756,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Del Guerra S,"

Phrase: "Marselli L,"

Phrase: "Bugliani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Boggi U,"

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marchetti P,"

Phrase: "Del Prato S"

Phrase: ":"

Phrase: "Rosiglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0289313:rosiglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the impairment of human islet function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "induced by fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0015684:Fatty Acids [Lipid]
   770   C0001128:Acids [Chemical]
   770   C0205263:Induced [Functional Concept]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "evidence for a role of PPARgamma2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.266: Am J Physiol Endocrinol Metab286 :E560 E567,2004[Abstract/Free FullText] da Silva XG, Leclerc I, Varadi A, Tsuboi T, Moule SK, Rutter GA: Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab286"

Phrase: ":"

Phrase: "E560 E567,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] da Silva XG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292284:XG [Body System]
   827   C1421532:XG [Gene or Genome]
   827   C2349046:xg [Quantitative Concept]

Phrase: "Leclerc I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Varadi A,"

Phrase: "Tsuboi T,"

Phrase: "Moule SK,"

Phrase: "Rutter GA"

Phrase: ":"

Phrase: "Role for AMP-activated protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "preproinsulin gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.267: Biochem J371 :761 774,2003[Medline] Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK, Ruderman NB: AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. 

Phrase: "Biochem J371"

Phrase: ":"

Phrase: "761 774,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kelly M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Keller C,"

Phrase: "Avilucea PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Keller P,"

Phrase: "Luo Z,"

Phrase: "Xiang X,"

Phrase: "Giralt M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hidalgo J,"

Phrase: "Saha AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Pedersen BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Ruderman NB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: ":"

Phrase: "AMPK activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3546468:AMPK activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "diminished in tissues of IL-6 knockout mice"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   776   C3658127:IL-6, mouse [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0206745:Knock-out Mice [Mammal]
   770   C1334122:IL6 [Gene or Genome]
   770   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0020898:IL [Geographic Area]
   744   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0022271:IL [Geographic Area]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0040300:Tissues [Tissue]
   744   C0205216:Diminished [Quantitative Concept]
   744   C0560617:knock out [Injury or Poisoning]
   744   C1522225:Knock-out [Experimental Model of Disease]
   711 E C1547928:Tissue [Intellectual Product]

Phrase: ":"

Phrase: "the effect of exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.268: Biochem Biophys Res Commun320 :449 454,2004[Medline] Kuroki T, Isshiki K, King GL: Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. 

Phrase: "Biochem Biophys Res Commun320"

Phrase: ":"

Phrase: "449 454,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuroki T,"

Phrase: "Isshiki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ":"

Phrase: "the lead"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]
   916 E C0181586:leads [Medical Device]

Phrase: "or"

Phrase: "supporting actor in the pathogenesis of diabetic complications."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0335083:Actor [Professional or Occupational Group]
Processing 00000000.tx.269: J Am Soc Nephrol14 :S216 S220,2003[Free FullText] Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol14"

Phrase: ":"

Phrase: "S216 S220,"

Phrase: "2003"

Phrase: "[Free FullText"

Phrase: "] Quagliaro L,"

Phrase: "Piconi L,"

Phrase: "Assaloni R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Martinelli L,"

Phrase: "Motz E,"

Phrase: "Ceriello A"

Phrase: ":"

Phrase: "Intermittent high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0860803:high glucose [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "related to oxidative stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in human umbilical vein endothelial cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "the role of protein kinase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "NAD(P)H-oxidase activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1879547:Activation [Activity]
   771   C0068355:NAD(P)H oxidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.270: Diabetes52 :2795 2804,2003[Abstract/Free FullText] Shibata MA, Shirai T, Ogawa K, Takahashi S, Wild CP, Montesano R, Tsuda H, Ito N: DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "2795 2804,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shibata MA,"

Phrase: "Shirai T,"

Phrase: "Ogawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi S,"

Phrase: "Wild CP,"

Phrase: "Montesano R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tsuda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ito N"

Phrase: ":"

Phrase: "DNA methylation adduct formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1511660:DNA Adduct Formation [Cell or Molecular Dysfunction]
   902   C1817262:DNA formation [Genetic Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   708   C0242958:DNA Adduct [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "H-ras gene mutations in progression"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0079471:H-ras gene [Gene or Genome]
   833   C1533641:H-ras Gene [Gene or Genome]
   790   C0034677:RAS gene [Gene or Genome]
   790   C0596611:gene mutations [Genetic Function]
   790   C1705572:RAS Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of N-butyl-N-(4-hydroxybutyl"

Phrase: ")"

Phrase: "nitrosamine-induced bladder tumors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005695:Bladder Tumors [Neoplastic Process]
   812   C0005682:Bladder [Body Part, Organ, or Organ Component]
   812   C0027651:Tumors [Neoplastic Process]
   812   C1281573:Bladder [Body Part, Organ, or Organ Component]
   812   C1511200:Bladder [Tissue]
   779 E C1578706:Tumor [Intellectual Product]
   779 E C3273930:Tumor [Finding]
   756 E C0205058:Vesical [Spatial Concept]

Phrase: "caused by a single exposure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "to N-methyl-N-nitrosourea."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025803:N-Methyl-N-nitrosourea [Hazardous or Poisonous Substance,Organic Chemical]
   812   C0028210:nitrosourea [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.271: Carcinogenesis15 :2965 2968,1994[Abstract] Del Prato S, Tiengo A: The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. 

Phrase: "Carcinogenesis15"

Phrase: ":"

Phrase: "2965 2968,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Del Prato S,"

Phrase: "Tiengo A"

Phrase: ":"

Phrase: "The importance of first-phase insulin secretion"

Phrase: ":"

Phrase: "implications for the therapy of type 2 diabetes mellitus."
Processing 00000000.tx.272: Diabetes Metab Res Rev17 :164 174,2001[Medline] Carling D: The AMP-activated protein kinase cascadea unifying system for energy control. 

Phrase: "Diabetes Metab Res Rev17"

Phrase: ":"

Phrase: "164 174,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carling D"

Phrase: ":"

Phrase: "The AMP-activated protein kinase cascadea unifying system for energy control."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0680582:control system [Regulation or Law]
   738   C0449913:System [Functional Concept]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]
Processing 00000000.tx.273: Trends Biochem Sci29 :18 24,2004[Medline] Servitja JM, Ferrer J: Transcriptional networks controlling pancreatic development and beta cell function. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci29"

Phrase: ":"

Phrase: "18 24,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Servitja JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Ferrer J"

Phrase: ":"

Phrase: "Transcriptional networks"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1720950:Transcriptional Networks [Molecular Function]
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "pancreatic development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "beta cell function."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.274: Diabetologia47 :597 613,2004 Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH 3rd, Wright CV, White MF, Arden KC, Accili D: The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. 

Phrase: "Diabetologia47"

Phrase: ":"

Phrase: "597 613,"

Phrase: "2004 Kitamura T,"

Phrase: "Nakae J,"

Phrase: "Kitamura Y,"

Phrase: "Kido Y,"

Phrase: "Biggs WH 3rd,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205437:3rd [Quantitative Concept]
   827   C0442992:Biggs [Intellectual Product]
   827   C2349143:Wh [Quantitative Concept]

Phrase: "Wright CV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538987:CV [Idea or Concept]

Phrase: "White MF,"

Phrase: "Arden KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "Accili D"

Phrase: ":"

Phrase: "The forkhead transcription factor Foxo1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1333572:FOXO1 [Gene or Genome]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "insulin signaling to Pdx1 regulation of pancreatic beta cell growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C2756011:regulation of signaling [Biologic Function]
   757   C0037083:Cell Signaling [Cell Function]
           Signaling
   739   C3537152:signaling [Biologic Function]
Processing 00000000.tx.275: J Clin Invest110 :1839 1847,2002[Abstract/Free FullText] Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H: Glucose toxicity in -cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. 

Phrase: "J Clin Invest110"

Phrase: ":"

Phrase: "1839 1847,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Harmon J,"

Phrase: "Tran PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Tanaka Y,"

Phrase: "Takahashi H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Glucose toxicity in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "good radicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "gone"

Phrase: "bad,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "and"

Phrase: "the glutathione connection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449379:Connection [Intellectual Product]
Processing 00000000.tx.276: Diabetes52 :581 587,2003[Abstract/Free FullText] Brownlee M: A radical explanation for glucose-induced beta cell dysfunction. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "581 587,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "A radical explanation for glucose-induced beta cell dysfunction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.277: J Clin Invest112 :1788 1790,2003[Abstract/Free FullText] Steiner DF, James DE: Cellular and molecular biology of the beta cell. 

Phrase: "J Clin Invest112"

Phrase: ":"

Phrase: "1788 1790,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Steiner DF,"

Phrase: "James DE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: ":"

Phrase: "Cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular biology of the beta cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   783   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.278: Diabetologia35 (Suppl. 2) :S41 S48,1992[Medline] Lenzen S, Tiedge M: Regulation of pancreatic B-cell glucokinase and GLUT2 glucose transporter gene. 

Phrase: "Diabetologia35"

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "S41 S48,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lenzen S,"

Phrase: "Tiedge M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Regulation of pancreatic B-cell glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "GLUT2 glucose transporter gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.279: Biochem Soc Trans22 :1 6,1994[Medline] Matschinsky FM: Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. 

Phrase: "Biochem Soc Trans22"

Phrase: ":"

Phrase: "1 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matschinsky FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "Regulation of pancreatic beta-cell glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "from basics"

Phrase: "to therapeutics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
  1000   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.280: Diabetes51 (Suppl. 3) :S394 S404,2002[Medline] Bouch C, Serdy S, Kahn CR, Goldfine AB: The cellular fate of glucose and its relevance in type 2 diabetes. 

Phrase: "Diabetes51"

Phrase: "(Suppl. 3"

Phrase: ")"

Phrase: ":"

Phrase: "S394 S404,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bouch C,"

Phrase: "Serdy S,"

Phrase: "Kahn CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Goldfine AB"

Phrase: ":"

Phrase: "The cellular fate of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1539479:FATE [Gene or Genome]

Phrase: "and"

Phrase: "its relevance in type 2 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.281: Endocr Rev25 :807 830,2004[Abstract/Free FullText] Henquin JC, Ravier MA, Nenquin M, Jonas JC, Gilon P: Hierarchy of the beta-cell signals controlling insulin secretion. 

Phrase: "Endocr Rev25"

Phrase: ":"

Phrase: "807 830,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henquin JC,"

Phrase: "Ravier MA,"

Phrase: "Nenquin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jonas JC,"

Phrase: "Gilon P"

Phrase: ":"

Phrase: "Hierarchy of the beta-cell signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0699032:Hierarchy [Functional Concept]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.282: Eur J Clin Invest33 :742 750,2003[Medline] Maechler P, Wollheim C: Mitochondrial function in normal and diabetic beta-cells. 

Phrase: "Eur J Clin Invest33"

Phrase: ":"

Phrase: "742 750,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maechler P,"

Phrase: "Wollheim C"

Phrase: ":"

Phrase: "Mitochondrial function in normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "diabetic beta-cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.283: Nature414 :807 812,2001[Medline] Akkan AG, Malaisse WJ: Insulinotropic action of AICA riboside. 

Phrase: "Nature414"

Phrase: ":"

Phrase: "807 812,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akkan AG,"

Phrase: "Malaisse WJ"

Phrase: ":"

Phrase: "Insulinotropic action of AICA riboside."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]
Processing 00000000.tx.284: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.285: Insulin release by isolated islets and the perfused pancreas. 

Phrase: "Insulin release by isolated islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "the perfused pancreas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.286: Diabetes Res25 :13 23,1994[Medline] Melloul D: Transcription factors in islet development and physiology: Role of PDX-1 in beta-cell function. 

Phrase: "Diabetes Res25"

Phrase: ":"

Phrase: "13 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Melloul D"

Phrase: ":"

Phrase: "Transcription factors in islet development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Transcription [Genetic Function]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: ":"

Phrase: "Role of PDX-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in beta-cell function."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.287: Ann N Y Acad Sci1014 :28 37,2004[Abstract/Free FullText] Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. 

Phrase: "Ann N Y Acad Sci1014"

Phrase: ":"

Phrase: "28 37,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson RP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: ":"

Phrase: "Chronic oxidative stress as a central mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "for glucose toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "in pancreatic islet beta cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C0734999:Pancreatic islet cell [Cell]
   875   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   858 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.288: J Biol Chem279 :42351 42354,2004[Free FullText] Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S: Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. 

Phrase: "J Biol Chem279"

Phrase: ":"

Phrase: "42351 42354,"

Phrase: "2004"

Phrase: "[Free FullText"

Phrase: "] Lortz S,"

Phrase: "Tiedge M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nachtwey T,"

Phrase: "Karlsen AE,"

Phrase: "Nerup J,"

Phrase: "Lenzen S"

Phrase: ":"

Phrase: "Protection of insulin-producing RINm5F cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0524828:Cell Protection [Physiologic Function]
   753   C1545588:Protection [Finding]

Phrase: "against cytokine-mediated toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "through overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of antioxidant enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.289: Diabetes49 :1123 1230 Paolisso G, Giugliano D, Pizza G, Gambardella A, Tesauro P, Varricchio M, DOnofrio F: Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "1123 1230 Paolisso G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Giugliano D,"

Phrase: "Pizza G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Gambardella A,"

Phrase: "Tesauro P,"

Phrase: "Varricchio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "DOnofrio F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Glutathione infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "potentiates"

Phrase: "glucose-induced insulin secretion in aged patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1256369:insulin secretion [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "with impaired glucose tolerance."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]
Processing 00000000.tx.290: Diabetes Care15 :1 7,1992[Abstract] Lupi R, Marselli L, Dionisi S, Del Guerra S, Boggi U, Del Chiaro M, Lencioni C, Bugliani M, Mosca F, Di Mario U, Del Prato S, Dotta F, Marchetti P: Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients. 

Phrase: "Diabetes Care15"

Phrase: ":"

Phrase: "1 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lupi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Marselli L,"

Phrase: "Dionisi S,"

Phrase: "Del Guerra S,"

Phrase: "Boggi U,"

Phrase: "Del Chiaro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Lencioni C,"

Phrase: "Bugliani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mosca F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Mario U,"

Phrase: "Del Prato S,"

Phrase: "Dotta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marchetti P"

Phrase: ":"

Phrase: "Improved insulin secretory function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0544458:Secretory function [Functional Concept]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "reduced chemotactic properties after tissue culture of islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "from type 1 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.291: Diabetes Metab Res Rev20 :246 521,2004[Medline]

Phrase: "Diabetes Metab Res Rev20"

Phrase: ":"

Phrase: "246 521,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

